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Autophagy is a catabolic pathway that degrades damaged proteins and 
organelles in lysosome; however, the exact role of autophagy in cardiac function in 
physiological and pathological states is incompletely understood.  
To investigate the role of autophagy in the heart, we generated a cardiac-specific 
autophagy-deficient mouse model with deletion of ATG3 gene (cATG3 KO) in 
cardiomyocytes. ATG3-deficient hearts exhibited reduced ATG3 protein and decreased 
autophagic flux. cATG3 KO mice developed cardiac contractile dysfunction at 4 weeks 
old in the absence of fibrosis. Mitochondrial function was impaired in cATG3 KO mouse 
hearts at 1 week old, which precedes cardiac contractile dysfunction. Interestingly, we 
found that NAD+ metabolic flux was altered in cATG3 KO mouse hearts, characterized 
by increased nicotinamide N-Methyltransferase (NNMT) expression and accelerated 
NAD+ degradation. NNMT overexpression was sufficient to cause mitochondrial 
dysfunction and NNMT inhibition prevented mitochondrial dysfunction in CQ-treated 
H9C2 cells. Moreover, nicotinamide mononucleotide (NMN), the precursor of NAD+, 
raised cardiac NAD+ content and rescued cardiac contractile dysfunction in cATG3 KO 
mice. These data suggest that autophagy plays an essential role in maintaining cardiac 
function by regulating NNMT expression and NAD+ homeostasis in the heart.  
Exercise training has been shown to be beneficial for cardiac function, although 
the exact molecular mechanism is unclear. To investigate the role of autophagy in 
maintaining cardiac homeostasis under exercise conditions, mice with germline haplo-




training, and wild-type (WT) mice were used as control. Compared to WT mice, beclin 1 
heterozygous mice exhibited impaired autophagy in response to exercise training. 
Interestingly, we found mitochondrial biogenesis and cardiac contractile function 
improvement was attenuated after exercise training in beclin 1 heterozygous mouse 
heart. These results indicate autophagy also plays an essential role for mediating the 
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Autophagy Plays an Essential Role in Cellular Homeostasis 
Basic autophagy process  
Autophagy is an essential cellular process to break down cellular components in 
a lysosome-dependent pathway. There are three major types of autophagy —
macroautophagy, microautophagy, and chaperone-mediated autophagy [1, 2]. The term 
“autophagy” indicates macroautophagy if not specified.  
In macroautophagy, certain long-lived proteins, damaged organelles and 
malformed proteins are sequestered in vacuoles termed as autophagosomes, and 
subsequently delivered to lysosomes for degradation [3] [4] [5].  Currently, 32 different 
autophagy-related genes (ATG) have been identified in yeast and many of these genes 
are found to be conserved in mammals, emphasizing the importance of autophagy in 
various biological processes [6]. 
Autophagy is a multistep process. Basically, there are 5 main steps, including 
vesicle nucleation, vesicle elongation, autophagosome structure formation, 
autophagosome fusion with lysosomes, and eventually, vesicle breakdown and 
degradation inside the lysosome (Figure 1.1) [5].  In the first step of autophagosome 
formation, cytoplasmic components, including damaged organelles, are sequestered by 
a unique double membrane called the phagophore. Complete sequestration by the 
elongating phagophore results in formation of the double-membraned autophagosome. 
LC3, a mammalian homolog of ATG8, targets autophagosome inner membrane and 






In the course of autophagy, a cytosolic form of LC3 (LC3 I) is conjugated to 
phosphatidylethanolamine to form LC3-phosphatidylethanolamine conjugate (LC3 II), 
which is recruited to autophagosome membranes [1]. Thus, LC3 II/I ratio or LC3 II levels 
are commonly used as the marker of autophagosome formation and autophagy 
induction. After autophagosomes are formed, p62/SQSTM1 binds to LC3 II and is 
selectively degraded in lysosomes [8] [9]. Since p62/SQSTM1 has an ubiquitin-binding 
domain, ubiquitinated proteins can be recruited to the autophagosome membrane 
through their interaction with p62/SQSTM1 [9]. Therefore, p62/SQSTM1 can be 
regarded as an autophagic adapter for selective degradation of ubiquitinated proteins. 
Besides LC II level, cytosolic p62/SQSTM1 (p62) level is another marker of autophagic 
flux (Figure 1.2).   
Autophagy regulatory machinery  
Several autophagy-related proteins (ATG) are involved in the regulation of 
autophagy vesicle initiation and autophagosome membrane elongation. The most well 
studied ATG in autophagy is beclin 1, the mammalian orthologue of yeast ATG6. Beclin 
1 plays an essential role in the initiation of autophagy. Under starvation or other stress 
conditions, beclin 1 is highly induced and dissociates from Bcl-2. The formed beclin 1-
Vps34-Vps15 core complex is essential for the initiation of autophagy [10] [11]. With the 
heterozygous deletion of bclin 1, autophagy was partially inhibited in multiple tissues, 
and beclin 1 heterozygous mice are widely used as a universal model to study 
autophagy in multiple tissues, including in liver, heart and lung [11].  
In autophagosome elongation, it has been well demonstrated that autophagy 
mainly depends on the function of ATG5, ATG7 and ATG3. ATG7 provides E1 
conjugating enzyme activity to form an ATG12-ATG5-ATG16 conjugating tricomplex. 






LC3 II to phosphatidylethanolamine (PE) for selective targeting to the autophagosomal 
membrane. The conjugated LC3 II-PE promotes autophagosome membrane elongation 
and autophagosome maturation (Figure 1.3) [12-14].  
In a recent study a small amount of autophagosome formation was found in 
ATG7 and ATG5 knockout (KO) MEFs when subjected to certain stressors, suggesting 
the existence of an ATG7/ATG5 independent autophagy pathway. This alternative 
pathway of autophagy was independent of LC3 processing, but still involved 
autophagosome formation from late endosomes [15]. But compared to the conventional 
LC3-dependent autophagy pathway, LC3-independent pathway contributes to a 
relatively minor component of autophagic flux in mammalian cells, and may be negligible 
in most cases. 
Autophagy maintains cellular homeostasis  
Autophagy is a constitutive process that maintains cellular homeostasis and 
serves an essential cellular quality control function. Under basal conditions, certain 
misfolded proteins and damaged organelles can be degraded and recycled by 
autophagy [2, 16]. Neuron-specific ATG7 knockout mice exhibited more ubiquitinated 
protein aggregates in the brain [17], ATG7-deficient hepatocytes showed accumulated 
peroxisomes [18], and ATG7 null β cells had abnormally Golgi structure [19]. ATG5 
or ATG7-deficient skeletal muscle accumulated abnormal mitochondria and ubiquitin-
positive proteins [20] [21]. These studies suggest that autophagy plays a crucial role by 
promoting ubiquitinated protein turnover, degrading aggregated proteins, as well as 
recycling damaged organelles.  
Besides, activation of autophagy also serves as a means of providing nutrients 
and energy to sustain vital cellular functions during a variety of stress conditions, 






hypoxia. In stress conditions, autophagy provides certain substrates for de novo protein 
synthesis and oxidative phosphorylation to maintain cellular biosynthesis and ATP 
production [22].  It has been found that ATG5 or ATG7 deficient mice exhibited reduced 
plasma and tissue amino acid levels, displayed signs of energy depletion and died within 
1 day after birth probably due to nutrient depletion [23] [18]. Cells with ATG7 knockdown 
or treated with the autophagy inhibitors chloroquine (CQ) showed more cell death under 
growth factor deprivation conditions. And supplying autophagy-deficient cells with the 
TCA cycle substrate methylpyruvate enhanced ATP production and rescued cell viability 
under growth factor deprivation conditions [24]. Thus under multiple stress conditions, 
autophagy functions as a cellular survival mechanism by modulating protein synthesis 
and cellular energy homeostasis [25]. 
Autophagy is involved in various human diseases  
Impaired autophagy was found to be associated with various human diseases 
such as neurodegeneration, myopathy, liver disease and type 2 diabetes [22]. In 
neurons, autophagy is believed to play a cytoprotective role by preventing protein 
aggregate formation. When ATG5 or ATG7 is deleted in neurons, these  ATG7 or ATG5 
KO mice show increased ubiquitinated aggregates and develop progressive 
neurodegeneration [26] [17].  In skeletal muscle, autophagy plays an essential role in 
maintaining muscle function, and muscle-specific ATG5 and ATG7 knockout mice 
showed muscle fiber dysfunction and develop severe muscle atrophy [20]. Besides 
neuron and skeletal muscle, the liver is another organ that is highly dependent on basal 
autophagy. ATG7 liver-specific KO mice showed increased triglyceride (TAG) levels, 
elevated total cholesterol levels and finally developed hepatomegaly, suggesting an 
essential role of autophagy in liver lipid metabolism regulation [27]. Autophagy has also 






developed progressive β cell degeneration, hyperglycemia, loss of insulin production, 
and cellular hypertrophy when fed a high fat diet (HFD), suggesting an essential role of 
autophagy in maintaining β cell function [28]. Moreover, in diabetic patients and db/db 
mice, autophagic flux are both repressed, indicating decreased autophagy may 
contribute to diabetes development [29] [30].  
Autophagy and Heart Health 
Autophagy in the heart under basal conditions 
Autophagy was also involved in multiple cardiovascular diseases. In one clinical 
study, mutations in genes encoding lysosome-associated membrane protein-2 (LAMP2), 
commonly known as Damon disease, were found to be strongly associated with 
profound myocardial hypertrophy and electrophysiologic defects, suggesting a causal 
relationship between autophagy defects and heart failure [31]. LAMP2 deficient mice 
were subsequently generated to study the role of LAMP2 in cardiac function. These 
LAMP2 deficient mice exhibited dramatically higher autophagic vacuole accumulation 
and decreased degradation of long-lived proteins in their cardiomyocytes. LAMP2 
deficient mice developed severe cardiomyopathy and showed elevated mortality, 
indicating the critical role of LAMP2 in maintaining cardiac function [32].  
In another mouse model, cardiac-specific deletion of ATG5 blocked autophagy in 
cardiomyocytes and caused cardiac contractile dysfunction [33]. Ultrastructural analyses 
of ATG5-deficient hearts demonstrated disorganized sarcomere structure and 
mitochondria misalignment [33]. These results indicate that constitutive autophagy is 
required for protein quality control and normal cardiomyocyte function. Isolated 
cardiomyocytes from ATG5-deficinet hearts were more susceptible than cardiomyocytes 
isolated from control hearts to isoproterenol [33]. These results indicate ATG5 is 






unclear due to the diverse biological role of ATG5 beyond autophagy. For instance, 
ATG5 has pro-apoptotic effects through its interaction with Bcl family. Truncated ATG5 
translocates from the cytosol to the mitochondria and associates with the antiapoptotic 
molecule Bcl-xL, which provokes apoptotic cell death. Thus the detrimental 
consequence of ATG5-deficiency in the heart could be the effect of activating apoptosis 
but not a secondary effect from autophagy inhibition [34]. 
Autophagy in the heart under pathological conditions 
In human failing hearts from subjects with dilated cardiomyopathy, large amounts 
of autophagic cells have been observed [35], suggesting that cardiac autophagy may 
play a role in heart failure progression. In a mouse model with pressure overload 
induced by transaortic constriction (TAC), mice developed heart failure and showed 
greatly increased cardiac autophagy for at least 3 weeks [36]. And another study 
showed autophagy was upregulated between 1 and 12 hours after TAC but was 
downregulated below physiological levels 5 days after TAC [37].  
Then more studies were conducted to investigate whether TAC-induced 
autophagy functions as a repair mechanism or contributes to cardiomyocyte cell death. 
In one study, using a whole body autophagy inhibition mouse model, heterozygous 
disruption of the beclin 1 gene, a protein required for early autophagosome initiation, 
decreased autophagy in cardiomyocytes and diminished pathological remodeling 
induced by pressure stress, suggesting cardiac autophagy may be a maladaptive 
response to hemodynamic stress. On the contrary, cardiac-specific ATG5 deficient mice 
developed severe cardiac dysfunction and left ventricular dilatation 1 week after TAC 
surgery [33], suggesting the protective role of autophagy in hemodynamic stress 
heart.  The obvious inconsistence between these two models might be due to the fact 






completely abrogated; whereas ATG5-deficient mice showed complete autophagy 
deficiency in cardiomyocytes.  
As a response to various stress conditions, autophagy has been found to be 
enhanced during ischemia and reperfusion (I/R) in the heart [38]. Forty minutes of 
ischemia caused more autophagosome formation, and reperfusion further increased 
autophagosome number, suggesting that I/R can induce autophagy in the heart [39]. 
Moreover, 30 minutes of ischemia and 2 hours of reperfusion induced LC3 II and beclin 
1 in Langendorff hearts, indicating autophagy may be evoked in response to I/R [40]. 
Autophagy could play a detrimental role during I/R, since blocking autophagy with 3-
methyladenine (3-MA) or LY294002 reduced cell death during glucose deprivation in 
cultured H9C2 cells [41], suggesting that autophagy contributes to cell death. 
Furthermore, inhibiting autophagy by beclin 1 knockdown or 3-Methyladenine (3-MA) 
treatment was sufficient to reduce cell death in cardiac myocytes after I/R stimulation 
[42]. Thus autophagy may play an adverse role during I/R in the heart. 
Autophagy may also modulate cardiac aging. It has been known that autophagic 
flux dramatically declines in old mouse and rat hearts [43, 44]. In the previously 
described ATG5 KO mouse model, ATG5 KO mice developed age-related cardiac 
dysfunction at 8 months old [45], suggesting a beneficial role of autophagy in preventing 
age-related cardiomyopathy. Moreover, overexpression of Parkin, a protein essential for 
mitophagy (mitochondrial autophagy), ameliorated the age-related decline of cardiac 
function [46], providing more evidence that autophagy plays a protective role in the aging 
heart.  
Exercise training, with multiple beneficial effects for cardiovascular health, is 
another well-known stress that robustly induces autophagic flux in the heart [47, 48]. 
Treadmill training increases autophagosome number in cardiac myocytes in LC3-GFP 






levels, were significantly  upregulated  in rat cardiac muscle after chronic exercise 
treadmill training, supporting the idea that autophagy is induced in the heart during 
exercise training [50]. However, the exact role of exercise-induced autophagy in cardiac 
remodeling remains incompletely understood. 
NAD+ in Cellular Function 
NAD+ modulates cellular function 
Nicotinamide adenine dinucleotide (NAD) is a central metabolic cofactor in cells 
either in its oxidized form (NAD+) or in its reduced form (NADH) [51]. NAD+ functions as 
a redox cofactor whose redox capacity is essential in cellular respiration.  By using NAD+ 
and the electron transport chain, the cell can produce ATP in a more efficient way 
through oxidation of organic molecules in mitochondria [52]. NAD+ is also functional as a 
critical “coenzyme” in a wide range of enzymatic reactions. In the cytosolic compartment, 
NAD+ regulates glycolytic flux by modulating enzymatic activity of glycolytic enzymes, 
such as Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) [53]. GAPDH modulates 
glycolysis rate, and its activity is largely affected by its co-substrate NAD+ concentration. 
Depletion of NAD+ by triggering Poly (ADP-ribose) polymerase 1 (PARP1) inhibits 
GAPDH activity and blocks glucose utilization in neuron cells [54].  Importantly, the 
reduction of glycolysis could be reversed by supplying 5 mM NAD+, suggestive of the 
importance of NAD+ content in regulating GADPH activity and cellular glycolytic rates 
[55].  
NAD+ can also regulate various biological reactions by modulation of sirtuin 
enzymatic activity. Seven sirtuins exist in mammalian cells (SIRT1-7), and all contain a 
conserved NAD-binding and catalytic domain [56]. The enzymatic activity of these 
sirtuins is highly dependent on NAD+, and connects cellular energy status with various 






[57]. For instance, NAD+ dependent enzyme SIRT1 regulates various biological 
functions depending on its tissue localization and plays a role in many 
pathophysiological processes, including obesity-associated metabolic diseases, cancer, 
adipose tissue differentiation, aging, cellular senescence, cardiac oxidative stress, 
neurodegeneration, inflammatory signaling and placental cell survival (Figure 1.4). Since 
its diverse role in regulating metabolic process and its activity is highly dependent on 
cellular NAD+ bioavailability, SIRT1 is regarded as a vital and sensitive energy sensor in 
adjusting biological systems. 
NAD+ biosynthetic and breakdown machinery 
Given its vital role in biological reactions, cellular NAD+ content is tightly 
controlled by multiple pathways. Basically, NAD+ metabolism is a balance between its 
biosynthesis and breakdown pathways (Figure 1.5).  
There are two biosynthetic pathways that generate NAD+. One is called de novo 
biosynthesis and the other is salvage pathway. In the NAD+ de novo biosynthesis 
pathway, tryptophan is converted to NAD+ through niacin and then to NAD+; however, 
this de novo pathway  is a relatively minor contributor to the total NAD pool in most 
organs [58]. Perhaps the more important NAD+ biosynthesis pathway is the salvage 
pathway, which can start either from nicotinic acid (NA), nicotinamide (NAM) or 
nicotinamide riboside (NR), all of  which are present in the regular diet [59]. For example, 
NR is present in milk and can be used to synthesize NAD in eukaryotes [60]. More 
importantly, NR supplementation can also increase NAD+ levels and trigger NAD-related 
downstream signaling both in cultured mammalian cells and in mice [61], rendering NR 
an important  dietary NAD+ precursor. Nicotinamide mononucleotide (NMN) is another 
key NAD+ intermediate that can be converted to NAD+ by one step reaction and 






There are various enzymes that consume NAD+, such as previously described 
SIRT family proteins and GAPDH [57] [62]. These NAD+ consumers utilize NAD as their 
co-substrate for enzymatic reaction, and degrade NAD to NAM. It should be noted that 
NAM can be recycled and synthesized to NAD+ in salvage pathway.  
For breakdown and clearance, NAM must be methylated to 1-methyl-
nicotinamide (MeNAM) by nicotinamide N-methyltransferase (NNMT) [63], and then 
further oxidized to 1-methyl-2-pyridone-5-carboxamide (Me-2PY) and 1-methyl-4-
pyridone-3-carboxamide (Me-4PY), which are excreted from tissue in urine [64]. Thus 
NNMT functions as the key enzyme in the NAD+ breakdown and degradation pathway, 
although its role in metabolism remains to be fully elucidated.  
NNMT in NAD+ metabolism 
NNMT is the enzyme that catalyzes the transfer of methyl groups from S-
adenosyl-1-methionine (SAM) to NAM, generating S-adenosylhomocysteine (SAH) and 
MeNAM for NAD+ breakdown. NNMT may be involved in multiple human diseases 
models. For example, NNMT was initially identified as a biomarker in a variety of human 
cancers, including in lung cancer, bladder cancer and colon cancer [65]. More studies 
show that NNMT is sufficient to promote the migration, invasion, proliferation and 
survival of cancer cells. NNMT also impairs the methylation potential of cancer cells by 
altering the cellular SAM/SAH ratio [66]. NNMT expression has also been shown to be 
tightly associated with Parkinson’s disease, as evidenced by increased NNMT 
expression in the brains from patients with Parkinson’s disease [67].  
Recently, NNMT has recently been implicated in multiple metabolic diseases.  
MeNAM concentrations are increased in the urine from multiple type 2 diabetes models, 
including db/db mice, obese Zucker rats and type 2 diabetes patients, suggesting that 






NNMT mRNA and protein levels were found to be significantly induced in white adipose 
tissue (WAT) from adipose-specific GLUT4 knockout mice, an animal model with 
systemic insulin resistance. Interestingly, NNMT knockdown in WAT and liver was 
sufficient to protect against diet-induced obesity by increasing NAD+ levels and by 
increasing cellular energy expenditure [69]. This study highlights the important role of 
NNMT in maintenance of NAD+ homeostasis and therefore NNMT is emerging as a 
novel target for metabolic disease therapy. 
NAD+ Is Emerging New Therapeutic Target for Heart Diseases 
Altered NAD+ metabolism has been described in various forms of heart disease. 
In pathological cardiac hypertrophy, NAD+ levels are reduced in mouse hearts after 
transverse aortic constriction (TAC) [70]. Moreover, intracellular levels of NAD+ are also 
decreased in agonist-induced pathological cardiac hypertrophy models, but not in 
exercise-induced physiological hypertrophy [71]. These results suggest there is an 
association between NAD+ content and pathological cardiac hypertrophy. Interestingly, 
supplying mice with NAD+ prevented the development of cardiac hypertrophy and 
blunted fibrosis as a response to angiotensin II [71]. In a recent study, overexpression of 
nicotinamide phosphoribosyltransferase (NAMPT), the enzyme for NAD+ biosynthesis, in 
cardiomyocytes, preserved myocardial NAD+ levels [72]. These results illustrate the 
essential role of NAD+ in maintaining cardiac function under pressure overload 
conditions. 
NAD+ also plays an important role in ischemia/reperfusion (I/R) in the heart. 
Following ischemia, NAD+ content is significantly reduced and this decline persists in 24 
hours following reperfusion [73]. The depleted NAD+ during I/R is thought to contribute 
to myocyte damage. In an earlier study, nicotinamide-rich diets protected the heart 






or NMN administration was sufficient to reduce the infarct area after I/R [73, 75]. 
Cardiac-specific overexpression of NAMPT increased NAD+ content in the heart, and 
reduced apoptosis and myocardial infarction size following ischemia/reperfusion [76]. 
Therefore, NAD+ homeostasis plays a critical role in cardiac function under basal and 
stress conditions, but the molecular mechanisms that regulate NAD+ content in the heart 
remain incompletely understood. 
The Interaction Between Autophagy and NAD+ Metabolism 
Many studies support an association between autophagy and NAD+ 
homeostasis. In xeroderma pigmentosum (XP) disease, a neuron degenerative disorder, 
decreased autophagy was observed in the neurons from XP patients, which was 
accompanied by reduced NAD+ content and impaired SIRT1 signaling. Moreover, 
nicotinamide riboside (NR), the precursor of NAD+, is sufficient to rescue the autophagy 
deficiency and mitochondrial dysfunction phenotype, suggesting an interaction between 
NAD+ depletion and autophagy deficiency in neuron cells [77].  
Dysfunctional autophagy has been widely observed in aging organisms and age-
related diseases [78], and reduced NAD+ content is another feature of these aged 
organisms [79]. In a recent study, decreased autophagic flux and reduced NAD+ levels 
were found in oxidative stress-induced senescent fibroblasts, suggesting autophagy 
deficiency and NAD+ depletion are jointly involved in aging related cell death [80]. 
However, the mechanism linking autophagic flux and NAD+ homeostasis is unknown. 
An association of autophagy deficiency and NAD+ depletion is also present in the 
failing heart. Transferrin receptor (TFR) knockout mice developed lethal cardiomyopathy 
due to iron deficiency in the heart. Interestingly, there was ineffective autophagy and 
altered NAD+ related gene expression in TFR deficient cardiomyocytes, suggestive of 






administration of nicotinamide riboside (NR) raised cardiac NAD+ content, rescued the 
autophagy defect and ameliorated cardiomyopathy in TFR KO mice [81]. These results 
suggest a potential interaction between autophagy and NAD+ homeostasis in the heart. 
Summary 
Autophagy, as a cellular process to maintain cellular homeostasis, is altered in 
various heart diseases models. However, gaps remain in our knowledge regarding the 
relationship between autophagy and cardiac structure, function and metabolism. NAD+ is 
an important redox cofactor and plays a vital role in maintaining normal cardiac function. 
Based on previous studies, autophagy deficiency and NAD+ depletion coexist in the 
aging heart and in multiple heart failure models, indicating there might be an interaction 
between autophagy and NAD+ homeostasis in the heart. In the following study, we 
investigated the role of autophagy in the heart under basal and exercise-training 
conditions. And we sought to understand the interaction between autophagy and NAD+ 







1. Mizushima, N., Autophagy: process and function. Genes Dev, 2007. 21(22): p. 
2861-73. 
2. Parzych, K.R. and D.J. Klionsky, An overview of autophagy: morphology, 
mechanism, and regulation. Antioxid Redox Signal, 2014. 20(3): p. 460-73. 
3. Nakatogawa, H., et al., Dynamics and diversity in autophagy mechanisms: 
lessons from yeast. Nat Rev Mol Cell Biol, 2009. 10(7): p. 458-67. 
4. Mizushima, N., et al., Autophagy fights disease through cellular self-digestion. 
Nature, 2008. 451(7182): p. 1069-75. 
5. Melendez, A. and B. Levine, Autophagy in C. elegans. WormBook, 2009: p. 1-26. 
6. Glick, D., S. Barth, and K.F. Macleod, Autophagy: cellular and molecular 
mechanisms. J Pathol, 2010. 221(1): p. 3-12. 
7. Kirisako, T., et al., The reversible modification regulates the membrane-binding 
state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole 
targeting pathway. J Cell Biol, 2000. 151(2): p. 263-76. 
8. Bjorkoy, G., et al., p62/SQSTM1 forms protein aggregates degraded by 
autophagy and has a protective effect on huntingtin-induced cell death. J Cell 
Biol, 2005. 171(4): p. 603-14. 
9. Pankiv, S., et al., p62/SQSTM1 binds directly to Atg8/LC3 to facilitate 
degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem, 
2007. 282(33): p. 24131-45. 
10. Liang, X.H., et al., Protection against fatal Sindbis virus encephalitis by beclin, a 
novel Bcl-2-interacting protein. J Virol, 1998. 72(11): p. 8586-96. 
11. Kang, R., et al., The beclin 1 network regulates autophagy and apoptosis. Cell 
Death Differ, 2011. 18(4): p. 571-80. 
12. Jia, W., et al., Autophagy, a novel pathway to regulate calcium mobilization in T 
lymphocytes. Front Immunol, 2013. 4: p. 179. 
13. Levine, B., N. Mizushima, and H.W. Virgin, Autophagy in immunity and 
inflammation. Nature, 2011. 469(7330): p. 323-35. 
14. Yamada, Y., et al., The crystal structure of Atg3, an autophagy-related ubiquitin 
carrier protein (E2) enzyme that mediates Atg8 lipidation. J Biol Chem, 2007. 
282(11): p. 8036-43. 
15. Nishida, Y., et al., Discovery of Atg5/Atg7-independent alternative 
macroautophagy. Nature, 2009. 461(7264): p. 654-8. 
16. Yi, C., et al., Function and molecular mechanism of acetylation in autophagy 






17. Komatsu, M., et al., Loss of autophagy in the central nervous system causes 
neurodegeneration in mice. Nature, 2006. 441(7095): p. 880-4. 
18. Komatsu, M., et al., Impairment of starvation-induced and constitutive autophagy 
in Atg7-deficient mice. J Cell Biol, 2005. 169(3): p. 425-34. 
19. Jung, H.S., et al., Loss of autophagy diminishes pancreatic beta cell mass and 
function with resultant hyperglycemia. Cell Metab, 2008. 8(4): p. 318-24. 
20. Masiero, E., et al., Autophagy is required to maintain muscle mass. Cell Metab, 
2009. 10(6): p. 507-15. 
21. Thapaliya, S., et al., Alcohol-induced autophagy contributes to loss in skeletal 
muscle mass. Autophagy, 2014. 10(4): p. 677-90. 
22. Murrow, L. and J. Debnath, Autophagy as a stress-response and quality-control 
mechanism: implications for cell injury and human disease. Annu Rev Pathol, 
2013. 8: p. 105-37. 
23. Kuma, A., et al., The role of autophagy during the early neonatal starvation 
period. Nature, 2004. 432(7020): p. 1032-6. 
24. Lum, J.J., et al., Growth factor regulation of autophagy and cell survival in the 
absence of apoptosis. Cell, 2005. 120(2): p. 237-48. 
25. Das, G., B.V. Shravage, and E.H. Baehrecke, Regulation and function of 
autophagy during cell survival and cell death. Cold Spring Harb Perspect Biol, 
2012. 4(6). 
26. Hara, T., et al., Suppression of basal autophagy in neural cells causes 
neurodegenerative disease in mice. Nature, 2006. 441(7095): p. 885-9. 
27. Singh, R., et al., Autophagy regulates lipid metabolism. Nature, 2009. 458(7242): 
p. 1131-5. 
28. Ebato, C., et al., Autophagy is important in islet homeostasis and compensatory 
increase of beta cell mass in response to high-fat diet. Cell Metab, 2008. 8(4): p. 
325-32. 
29. Masini, M., et al., Autophagy in human type 2 diabetes pancreatic beta cells. 
Diabetologia, 2009. 52(6): p. 1083-6. 
30. Li, X., et al., Islet microvasculature in islet hyperplasia and failure in a model of 
type 2 diabetes. Diabetes, 2006. 55(11): p. 2965-73. 
31. Arad, M., J.G. Seidman, and C.E. Seidman, Phenotypic diversity in hypertrophic 
cardiomyopathy. Hum Mol Genet, 2002. 11(20): p. 2499-506. 
32. Stypmann, J., et al., LAMP-2 deficient mice show depressed cardiac contractile 
function without significant changes in calcium handling. Basic Res Cardiol, 






33. Nakai, A., et al., The role of autophagy in cardiomyocytes in the basal state and 
in response to hemodynamic stress. Nat Med, 2007. 13(5): p. 619-24. 
34. Yousefi, S., et al., Calpain-mediated cleavage of Atg5 switches autophagy to 
apoptosis. Nat Cell Biol, 2006. 8(10): p. 1124-32. 
35. Kostin, S., et al., Myocytes die by multiple mechanisms in failing human hearts. 
Circ Res, 2003. 92(7): p. 715-24. 
36. Zhu, H., et al., Cardiac autophagy is a maladaptive response to hemodynamic 
stress. J Clin Invest, 2007. 117(7): p. 1782-93. 
37. Shirakabe, A., et al., Drp1-dependent mitochondrial autophagy plays a protective 
role against pressure overload-induced mitochondrial dysfunction and heart 
failure. Circulation, 2016. 133(13): p. 1249-63. 
38. Hamacher-Brady, A., N.R. Brady, and R.A. Gottlieb, Enhancing macroautophagy 
protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem, 
2006. 281(40): p. 29776-87. 
39. Hamacher-Brady, A., et al., Response to myocardial ischemia/reperfusion injury 
involves Bnip3 and autophagy. Cell Death Differ, 2007. 14(1): p. 146-57. 
40. Gurusamy, N., et al., Cardioprotection by adaptation to ischaemia augments 
autophagy in association with BAG-1 protein. J Cell Mol Med, 2009. 13(2): p. 
373-87. 
41. Aki, T., et al., Phosphoinositide 3-kinase accelerates autophagic cell death during 
glucose deprivation in the rat cardiomyocyte-derived cell line H9c2. Oncogene, 
2003. 22(52): p. 8529-35. 
42. Valentim, L., et al., Urocortin inhibits beclin1-mediated autophagic cell death in 
cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol, 
2006. 40(6): p. 846-52. 
43. De Meyer, G.R., G.W. De Keulenaer, and W. Martinet, Role of autophagy in 
heart failure associated with aging. Heart Fail Rev, 2010. 15(5): p. 423-30. 
44. Wohlgemuth, S.E., et al., Autophagy in the heart and liver during normal aging 
and calorie restriction. Rejuvenation Res, 2007. 10(3): p. 281-92. 
45. Taneike, M., et al., Inhibition of autophagy in the heart induces age-related 
cardiomyopathy. Autophagy, 2010. 6(5): p. 600-6. 
46. Hoshino, A., et al., Cytosolic p53 inhibits Parkin-mediated mitophagy and 
promotes mitochondrial dysfunction in the mouse heart. Nat Commun, 2013. 4: 
p. 2308. 
47. Gielen, S., G. Schuler, and V. Adams, Cardiovascular effects of exercise training: 






48. Driscoll, S.D., et al., Effects of exercise training and metformin on body 
composition and cardiovascular indices in HIV-infected patients. AIDS, 2004. 
18(3): p. 465-73. 
49. He, C., et al., Exercise-induced BCL2-regulated autophagy is required for muscle 
glucose homeostasis. Nature, 2012. 481(7382): p. 511-5. 
50. McMillan, E.M., et al., Autophagic signaling and proteolytic enzyme activity in 
cardiac and skeletal muscle of spontaneously hypertensive rats following chronic 
aerobic exercise. PLoS One, 2015. 10(3): p. e0119382. 
51. Berger, F., M.H. Ramirez-Hernandez, and M. Ziegler, The new life of a 
centenarian: signalling functions of NAD(P). Trends Biochem Sci, 2004. 29(3): p. 
111-8. 
52. Timashev, S.F., [Role of intermembrane electrical fields in electron and proton 
transport along the respiratory chain of mitochondria]. Biofizika, 1981. 26(6): p. 
1027-32. 
53. Schmalhausen, E.V., A.P. Pleten, and V.I. Muronetz, Ascorbate-induced 
oxidation of glyceraldehyde-3-phosphate dehydrogenase. Biochem Biophys Res 
Commun, 2003. 308(3): p. 492-6. 
54. Ying, W., et al., Tricarboxylic acid cycle substrates prevent PARP-mediated 
death of neurons and astrocytes. J Cereb Blood Flow Metab, 2002. 22(7): p. 774-
9. 
55. Alano, C.C., et al., NAD+ depletion is necessary and sufficient for poly(ADP-
ribose) polymerase-1-mediated neuronal death. J Neurosci, 2010. 30(8): p. 2967-
78. 
56. Frye, R.A., Phylogenetic classification of prokaryotic and eukaryotic Sir2-like 
proteins. Biochem Biophys Res Commun, 2000. 273(2): p. 793-8. 
57. Nakagawa, T. and L. Guarente, SnapShot: sirtuins, NAD, and aging. Cell Metab, 
2014. 20(1): p. 192-192 e1. 
58. Houtkooper, R.H., et al., The secret life of NAD+: an old metabolite controlling 
new metabolic signaling pathways. Endocr Rev, 2010. 31(2): p. 194-223. 
59. Magni, G., et al., Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci, 
2004. 61(1): p. 19-34. 
60. Bieganowski, P. and C. Brenner, Discoveries of nicotinamide riboside as a 
nutrient and conserved NRK genes establish a Preiss-Handler independent route 
to NAD+ in fungi and humans. Cell, 2004. 117(4): p. 495-502. 
61. Canto, C., et al., The NAD(+) precursor nicotinamide riboside enhances oxidative 
metabolism and protects against high-fat diet-induced obesity. Cell Metab, 2012. 






62. Mouchiroud, L., R.H. Houtkooper, and J. Auwerx, NAD(+) metabolism: a 
therapeutic target for age-related metabolic disease. Crit Rev Biochem Mol Biol, 
2013. 48(4): p. 397-408. 
63. Scheller, T., et al., Mouse liver nicotinamide N-methyltransferase 
pharmacogenetics: biochemical properties and variation in activity among inbred 
strains. Pharmacogenetics, 1996. 6(1): p. 43-53. 
64. Felsted, R.L. and S. Chaykin, N1-methylnicotinamide oxidation in a number of 
mammals. J Biol Chem, 1967. 242(6): p. 1274-9. 
65. Roessler, M., et al., Identification of nicotinamide N-methyltransferase as a novel 
serum tumor marker for colorectal cancer. Clin Cancer Res, 2005. 11(18): p. 
6550-7. 
66. Ulanovskaya, O.A., A.M. Zuhl, and B.F. Cravatt, NNMT promotes epigenetic 
remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol, 
2013. 9(5): p. 300-6. 
67. Parsons, R.B., et al., High expression of nicotinamide N-methyltransferase in 
patients with idiopathic Parkinson's disease. Neurosci Lett, 2003. 342(1-2): p. 13-
6. 
68. Salek, R.M., et al., A metabolomic comparison of urinary changes in type 2 
diabetes in mouse, rat, and human. Physiol Genomics, 2007. 29(2): p. 99-108. 
69. Kraus, D., et al., Nicotinamide N-methyltransferase knockdown protects against 
diet-induced obesity. Nature, 2014. 508(7495): p. 258-62. 
70. Pillai, J.B., et al., Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte 
cell death during heart failure is mediated by NAD+ depletion and reduced 
Sir2alpha deacetylase activity. J Biol Chem, 2005. 280(52): p. 43121-30. 
71. Pillai, V.B., et al., Exogenous NAD blocks cardiac hypertrophic response via 
activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem, 2010. 
285(5): p. 3133-44. 
72. Yano, M., et al., Monocyte-derived extracellular Nampt-dependent biosynthesis 
of NAD(+) protects the heart against pressure overload. Sci Rep, 2015. 5: p. 
15857. 
73. Yamamoto, T., et al., Nicotinamide mononucleotide, an intermediate of NAD+ 
synthesis, protects the heart from ischemia and reperfusion. PLoS One, 2014. 
9(6): p. e98972. 
74. Sukhodub, A., et al., Nicotinamide-rich diet protects the heart against ischaemia-
reperfusion in mice: a crucial role for cardiac SUR2A. Pharmacol Res, 2010. 
61(6): p. 564-70. 
75. Trueblood, N.A., et al., Niacin protects the isolated heart from ischemia-






76. Hsu, C.P., et al., Nicotinamide phosphoribosyltransferase regulates cell survival 
through autophagy in cardiomyocytes. Autophagy, 2009. 5(8): p. 1229-31. 
77. Fang, E.F., et al., Defective mitophagy in XPA via PARP-1 hyperactivation and 
NAD(+)/SIRT1 reduction. Cell, 2014. 157(4): p. 882-96. 
78. Levine, B. and G. Kroemer, Autophagy in the pathogenesis of disease. Cell, 
2008. 132(1): p. 27-42. 
79. Yoshino, J., et al., Nicotinamide mononucleotide, a key NAD(+) intermediate, 
treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab, 
2011. 14(4): p. 528-36. 
80. Han, X., et al., AMPK activation protects cells from oxidative stress-induced 
senescence via autophagic flux restoration and intracellular NAD elevation. 
Aging Cell, 2016. 
81. Xu, W., et al., Lethal cardiomyopathy in mice lacking transferrin receptor in the 

















Figure 1.1 Autophagy is a multistep process, including vesicle nucleation, vesicle 
elongation, autophagosome formation, autophagosome fusion with the lysosome, 












Figure 1.2 p62/SQSTM1 functions as an adaptor for protein selective degradation. 
p62/SQSTM1 can bind with ubiquitinated proteins and then bind to LC3 II for selective 




















Figure 1.3 Autophagy-related (ATG) proteins and their interactions in the autophagy 
machinery. ATG7 functions as an E1 enzyme to form an ATG12–ATG5-ATG16 complex, 
providing E3 enzyme activity. ATG3 provides E2 enzyme activity, together with E3 















Figure 1.4 NAD+ dependent deacetylase SIRT1 plays a diverse role in mammalian cells 
in different tissues, including in neurons, adipocytes, beta cells, cardiomyocytes as well 














Figure 1.5 NAD+ can be converted from tryptophan through a de novo biosynthetic 
pathway, or recycled from nicotinamide riboside (NR) and nicotinamide mononucleotide 
(NMN) through the salvage pathway.  For degradation and clearance, NAD+ can be 





              






AUTOPHAGY MAINTAINS HEART FUNCTION BY MAINTAINING 
CARDIAC NAD+ HOMEOSTASIS 
Abstract 
Autophagy is a catabolic pathway that degrades damaged proteins and 
organelles in lysosomes. Altered autophagy has been implicated in various 
cardiovascular diseases; however, a full understanding of the role of autophagy in 
cardiovascular homeostasis in physiological and pathophysiological states is still 
evolving. In this study, we generated a cardiac-specific autophagy-deficient mouse 
model with deletion of the ATG3 gene in cardiomyocytes. Compared to WT mice, 
cardiac-ATG3 knockout (cATG3 KO) mice exhibited cardiac contractile dysfunction and 
decreased mitochondrial respiration. Interestingly, NAD+ metabolism was altered in 
ATG3-deficient hearts, characterized by increased nicotinamide N-methyltransferase 
(NNMT) expression. NNMT overexpression repressed mitochondrial respiration, while 
NNMT inhibition prevented mitochondrial dysfunction in autophagy deficient cells. 
Replenishing cardiac NAD+ content by nicotinamide mononucleotide (NMN) restored 
cardiac contractile function in cATG3 KO mice. These data suggest autophagy plays an 
essential role in cardiac physiology by maintaining NAD+ homeostasis. 
Introduction 
Autophagy is an evolutionarily conserved catabolic process by which cells break 






evidence has indicated that autophagy plays a central role in regulating cardiac 
structure and function under physiological and pathophysiological conditions [2]. For 
example, the increase in autophagy during early phases of pressure overload may 
function as an adaptive response to prevent cardiomyocyte apoptosis [3]. However, 
repression of autophagy may promote the transition from compensated cardiac 
hypertrophy to heart failure [3]. Cardiac ATG5 knockout (cATG5 KO) mice developed 
age-related cardiomyopathy, suggesting that autophagy may also function as an anti-
aging mechanism in the heart [4]. However many questions remain as to the exact role 
of autophagy in heart and these mechanisms need to be elucidated.  
Nicotinamide adenine dinucleotide (NAD+) is an important coenzyme involved in 
numerous metabolic enzymatic reactions including glycolysis, fatty acid β-oxidation, and 
the tricarboxylic acid (TCA) cycle [5]. Reduced NAD+ levels correlate with reduced 
number and density of mitochondria in aging organs [6]. NAD+ can also serve as a 
substrate for poly (ADP-ribose) polymerases (PARPs) and class III NAD-dependent 
deacetylases (Sirtuins 1-7) [7, 8], which regulate diverse biological processes including 
those involved in the pathophysiology of cancer and metabolic diseases [9-12].  
NAD+ plays a critical role in maintaining normal cardiac function. Impaired 
myocardial NAD+ homeostasis has been described in various cardiovascular diseases, 
including ischemia/reperfusion, myocardial infarction and dilated cardiomyopathy [13-
16]. Moreover, boosting NAD+ by pharmacological approaches improved cardiac 
function in various heart failure animal models [16]. These results suggest NAD+ 
homeostasis as an emerging therapeutic target for heart failure. 
ATG3 is a specific E2-like enzyme for the autophagosome conjugation system. 
It mediates the conversion of LC3 I to its active form LC3 II by conjugating 
phosphatidylethanolamine, which promotes autophagosome membrane elongation [17]. 






deficient mice died 1 day after birth [18, 19]. In the present study, we sought to 
elucidate the role of autophagy in the heart by generating cardiac-specific ATG3 
knockout (cATG3 KO) mice. Our results showed that cATG3 KO mice exhibited 
impaired autophagic flux in the heart and developed heart failure. Interestingly, we 
found that NAD+ metabolism was significantly changed in cATG3 KO mouse heart. 
Moreover, boosting cardiac NAD+ levels by nicotinamide mononucleotide (NMN) was 
sufficient to rescue cardiac contractile dysfunction in cATG3 KO mice. These results 
provide novel insights into the cross-talk between autophagy and NAD+ metabolism that 
impact cardiac function. 
Materials and Methods 
Animal experiments 
This study protocol was approved by the Institutional Animal Care and Use 
Committees of the University of Utah, and the Carver College of Medicine of the 
University of Iowa.  
Tissue harvest  
Random fed or fasted mice were anesthetized by chloral hydrate, and hearts 
were immediately removed and rinsed in cold phosphate-buffered saline (PBS) before 
being snap frozen in liquid nitrogen. For metabolomics analyses, hearts were 
immediately removed, freeze-clamped and rapidly submerged in liquid nitrogen.  
Cell culture and treatments 
All reagents were purchased from Sigma (St. Louis, MO) unless stated 
otherwise. H9C2 (rat embryonic cardiomyoblasts, ATCC, Manassas, VA) and Ad-293 
(ATCC, Manassas, VA) cells were maintained in DMEM (Invitrogen, Carlsbad, CA) with 






SiRNA knockdown and virus transfection 
For siRNA knockdown studies, H9C2 cells were transfected with 80 nM 
scramble or targeted siRNAs for 72 h using lipofectamine 2000 (Life Technologies, 
Eugene, OR). NNMT and GFP adenovirus were gifted from Dr.Pavlos Pissios from Beth 
Israel Deaconess Medical Center [20]. Cultured H9C2 cells were infected with 
adenovirus in DMEM medium with 25 mM glucose at a multiplicity of infection (MOI) of 
10. Then the viral infected H9C2 cells were cultured for an additional 48 h. 
Immunoprecipitation and immunoblotting 
Total proteins were extracted from hearts or cultured H9C2 cells in lysis buffer, 
containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 10% Glycerol, 1% Triton X-100, 1.5 
mM MgCl2, 1 mM EGTA, 10 mM Na4P2O7, 100 mM NaF, and 1X Halt protease and 
phosphatase inhibitor cocktail (Thermo Scientific, Rockford, IL) [21]. The protein 
concentration was determined using a micro BCA Protein Assay kit (Thermo Scientific, 
Rockford, IL). Immunoprecipitation was performed with Millipore (Billerica, MA) provided 
protocols: 0.5 mg protein lysates in 1 ml lysis buffer containing both protease and 
phosphatase inhibitors were incubated with 10 μg PGC1α antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA) at 4°C on a rocker for 3 h, and the antibody-protein 
complexes were later captured by protein A agarose beads (Millipore, Billerica,MA) by 
1-h incubation on a rocker at 4°C. The immunocomplexes were then dissociated from 
the beads by boiling with 2× Tris-glycine SDS sample buffer (Invitrogen, Carlsbad, CA) 
containing 5% β-mercaptoethanol at 95°C for 10 min. The supernatant was used for 
Western blot analysis. For immunoblotting, previous extracted proteins were resolved 
on SDS-PAGE and analyzed by western blotting using the LI-COR Odyssey Imager (LI-
COR Lincoln, NE), an infrared fluorescence based detection system. The following 






p62/SQSTM1 (P0067), and alpha-Tubulin (T8203) (Sigma-Aldrich, St. Louis, MO). 
Acetylated-Lysine (6952), Acetyl-α-Tubulin (Lys40), FOXO1 (2880), GAPDH (2118) and 
Parkin (4211) (Cell Signaling, Boston, MA). Ac-FKHR (D-19), NNMT (H-68), PGC1 α 
(H-300) and SIRT1 (B-10) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA ). 
NDUFA9 (complex I subunit), SDHA (complex II subunit), CytoC-regulatory core protein 
(complex III subunit), MTCO3 (complex IV subunit) and ATP5a (complex V subunit) 
antibodies (Abcam, Cambridge, MA). 
Carnitine palmitoyltransferase (CPT) activity measurement 
Mitochondria were isolated from fresh heart tissue as previously described [22]. 
Mitochondria were assayed in 1 ml of reaction buffer containing 20 mM HEPES, 1 mM 
EGTA, 220 mM sucrose, 40 mM KCl, 0.1 mM 5,5′-dithio-bis(2-nitrobenzoic acid) 
(DTNB), 1.3 mg/ml BSA, and 40 μM palmitoyl-CoA. The reaction was started by the 
addition of 1 mM carnitine and was monitored at 412 nm for an additional 4 min with an 
ultraspectral 3000 spectrophotometer. The measured CPT activity was normalized to 
mitochondrial protein. 
Citrate synthesis (CS) activity measurement 
Heart tissue was homogenized on ice in homogenization buffer containing 20 
mM HEPES and 10 mM EDTA at pH 7.4. Homogenates were subjected to two freeze 
and thaw cycles to liberate CS from the mitochondrial matrix and then diluted 1:10 to an 
approximate final protein concentration of 1 μg/μl. The reaction was performed in 1 ml 
of reaction buffer containing 20 mM HEPES, 1 mM EDTA, 220 mM sucrose, 40 mM 
KCl, 0.1 mM DTNB, and 0.1 mM acetyl-CoA (pH 7.4 at 25°C). The reaction was started 
by the addition of 0.05 mM oxaloacetate and monitored for 3 min with an ultrospectrol 







Cardiac tissue samples were removed and fixed in electron microscopy (EM) 
fixation buffer containing 2.5% glutaraldehyde and 1% paraformaldehyde. They were 
processed and overserved as previously described at the University of Utah Microscopy 
Core [23]. 
Echocardiography 
Mice were anesthetized with 2% isoflurane gas with an inflow rate of 1 ml/min 
and placed on a heated stage (37°C). Chest hair was then removed with a topical 
depilatory agent before the echocardiogram. Fractional shortening (in %) was 
calculated as 100 × [(LVDd − LVDs)/LVDd], where LVDd is the LV dimension at 
diastole and LVDs is the LV dimension at systole [22]. 
Glyceraldehyde 3 Phosphate Dehydrogenase (GAPDH)  
activity measurement 
Heart tissue was homogenized and GAPDH activity was measured as described 
according to manufacturer’s manual (Abcam,Cambridge, MA). NAD+ was added to the 
reaction buffer for a final concentration of 10 mM.   
Histology  
Myocardial fragments were stained with H&E (Thermo Scientific, Rockford, IL), 
Masson’s trichrome (Sigma-Aldrich, St. Louis, MO) or wheat germ agglutinin (Abcam, 
Cambridge, MA). Stained slides were analyzed as previously described [24]. 
Measurement of apoptosis 
Apoptosis was assessed in heart tissue using In Situ Cell Death Detection Kits 






Mitochondrial function in saponin-permeabilized cardiac fibers  
LV subendocardial muscle fibers were used to measure mitochondrial 
respiration rates and ATP synthesis as previously described [25]. Respiration rates 
were determined in the presence of substrate palmityl-carnitine (VO), after stimulation 
with 1 mM ADP (VADP), and after addition of 1 μg/ml of the ATP synthase inhibitor 
oligomycin (VOligo). ATP synthesis rate was measured in fibers after stimulation with 
1mM ADP. 
Mitochondrial oxygen consumption and glycolysis analysis 
The oxygen consumption and glycolytic rate were measured in cultured H9C2 
cells as described before [26]. H9C2 cells are seeded in Seahorse (Seahorse XF 
Analyzers, Seahorse Bioscience, North Billerica, MA ) cell culture plates. The basal 
oxygen consumption (OCR) and extracellular acidification (ECAR) rates were measured 
to establish baseline rates. The cells are then metabolically perturbed by following 
compounds in succession: 1 µg/ml oligomycin (Sigma-Aldrich, St. Louis, MO), 0.5 µg/ml 
FCCP (Sigma-Aldrich, St. Louis, MO), 1 µg/ml rotenone (Sigma-Aldrich, St. Louis, MO). 
NAD+ metabolic tracer assay 
WT mice or cATG3 KO mice were intraperitoneally injected with heavy-isotope 
labeled nicotinamide riboside (13C, D double labeled NR). At 0, 30 and 60 min after 
heavy-isotope labeled NR i.p. administration, mice were sacrificed and hearts were 
harvested. NAD+ and its metabolites were measured using LC-MS as shown in 
previous studies [27]. 
NAD+ metabolite measurement 
Hearts and livers from WT and cATG3 KO mice were freeze-clamped and 







β-Nicotinamide mononucleotide (NMN, N3501, Sigma-Aldrich, St. Louis, MO) 
was prepared in PBS and injected daily and continued for 7 days. NMN solution was 
administered intraperitoneally to 3-week-old mice at a dosage of 500 mg/kg body 
weight once a day for for 7 days. PBS (pH 7.4, Thermo Scientific, Rockford, IL) was 
injected in controls. 
Electron microscopy 
Cardiac tissue samples were removed and fixed in electron microscopy (EM) 
fixation buffer containing 2.5% glutaraldehyde and 1% paraformaldehyde. All samples 
were processed and analyzed as previously described, at the University of Utah 
Microscopy Core [23]. 
Echocardiography 
Mice were anesthetized with 2% isoflurane gas with an inflow rate of 1 ml/min 
and placed on a heated stage (37°C). Chest hair was then removed with a topical 
depilatory agent before the echocardiogram. Fractional shortening (in %) was 
calculated as 100 × [(LVDd − LVDs)/LVDd], where LVDd is the LV dimension at 
diastole and LVDs is the LV dimension at systole [22]. 
Quantitative PCR 
Total RNA was extracted from H9C2 cardiomyocytes using TRIzol reagent 
(Invitrogen), purified with the RNeasy kit (Qiagen, Valencia, CA) and reverse 
transcribed. Quantitative real-time PCR was performed using SYBR Green I with ROX 
as an internal reference dye. The expression level was normalized to the levels of 
RPL13A transcript. The primer sequences used for quantitative real-time PCR are listed 







Statistical analyses were performed using GraphPad Prism 6. All data are 
presented as mean ± SEM. Statistical significance (p<0.05) was determined by one-
way ANOVA then followed by unpaired Student’s t-test.  
Results 
cATG3 KO mice exhibited blocked autophagic flux in heart  
under fed and starvation conditions 
We crossed mice bearing floxed ATG3 alleles with transgenic mice expressing 
Cre recombinase under the control of α-myosin heavy chain promoter (α-MyHC). ATG3 
flox/flox, α-MyHC-Cre- littermates were used as wild-type (WT) controls (Figure 2.1A). 
Compared to WT mice, cardiac-specific ATG3 KO (cATG3 KO) mice exhibited 
significantly reduced ATG3 protein expression in the heart (Figure 2.1B). The LC3 II/I 
ratio was significantly decreased in cATG3 KO mouse heart but unchanged in their 
liver, skeletal muscle or adipose tissue (Figure 2.1C, 2.1D). SQSTM1/p62 was highly 
accumulated in cATG3 KO mouse heart (Figure 2.1C), indicating inhibition of 
autophagic flux. After 48 h of nutrient deprivation, autophagy was dramatically 
increased in WT mice hearts; however, this autophagy induction following starvation 
was totally blunted in ATG3-deficient hearts (Figure 2.1D).  
cATG3 KO mice developed cardiac contractile dysfunction 
and heart failure 
Echocardiogram data showed that at 4 months of age, cATG3 KO mice 
exhibited decreased fractional shortening compared with their WT littermates in both 
males and females (30.94 ± 0.90 % vs. 41.45  ± 1.44 %, p < 0.001; 33.21 ± 3.35 % vs. 
44.90  ± 1.00 %, p < 0.001), suggestive of impaired cardiac contractile function (Figure 






fed and starvation conditions (Figure 2.2B).  
We also found a 17% increase in ratio of heart weight (HW) to tibia length (BW) 
(7.04 ± 0.23 vs. 6.07 ± 0.16 mg/mm, p < 0.001) (Table 2.2). Moreover, 
the expression levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide 
(BNP) were significantly increased in ATG3-deficient hearts, indicating the existence of 
cardiac remodeling and pathological cardiac hypertrophy (Figure 2.2C). However, 
histological changes, such as inflammation, fibrosis, cardiomyocytes size, or apoptosis, 
were absent in cATG3 KO mice heart at 4 months of age (Figure 2.2D,E). 
Impaired fatty acid oxidation and increased lipid accumulation  
in cATG3 KO mouse hearts 
As adult heart's main source of fuel, fatty acids are transported to the 
mitochondria to undergo β-oxidation and generate ATP. Fatty acids not used for energy 
production can be esterified to tri-acyl glycerol (triglyceride, TAG) to provide an 
intracellular pool for fatty acids storage [28]. We observed that the expression levels of 
fatty acid oxidation (FAO) genes were decreased by up to 40% in cATG3 KO mice 
heart (Figure 2.S1A), accompanied by decreased carnitine palmitoyltransferase (CPT) 
activity (Figure 2.S1B) and increased TAG accumulation (Figure 2.S1C). The 
myocardial lipid accumulation in cATG3 KO mice hearts was confirmed using oil red O 
staining of sections (Figure 2.S1D), suggestive of impaired fatty acid oxidation and lipid 
accumulation in ATG3-deficient hearts.  
Mitochondrial respiration was impaired and mitochondrial  
content was lost in cATG3 KO mouse hearts 
Since mitochondria play a critical role in maintaining cardiac function, and 
mitochondrial dysfunction appears to be a critical factor in causing various heart 






fibers. Fibers obtained from cATG3 KO mouse heart revealed impaired palmitoyl-
carnitine supported ADP-stimulated mitochondrial oxygen consumption (VADP) and 
ATP production rate at 4 months old (Figure 2.3A,B). However, ATP/O ratios were not 
changed in cATG3 KO mice heart, suggestive of preserved mitochondrial coupling 
(data not shown). Citrate synthase activity, which reflects mitochondrial oxidation 
capacity [29], was also significantly reduced in cATG3 KO mouse heart (Figure 2.3C).  
Moreover, protein expression levels of mitochondrial complexes were decreased 
in cATG3 KO mouse hearts (Figure 2.3D), accompanied by a trend towards reduced 
mitochondrial DNA copy number (data not shown). We used transmission electron 
microscopy (TEM) to observe the morphology and structure of mitochondria in fixed 
heart sections. We found more abnormal morphology or disarrayed alignment in cATG3 
KO mice hearts (Figure 2.3E). Together, these data showed that mitochondrial content 
was reduced and function was impaired in cATG3 KO mouse heart. 
We then investigated the potential mechanism by which mitochondrial content 
was reduced in cATG3 KO mouse heart. Since mitochondrial content is a balance 
between producing new mitochondria through biogenesis and clearing damaged ones 
through autophagy, we suspected mitochondrial biogenesis was impaired in ATG3-
deficient hearts. Indeed, the expression PGC1 α, the master regulator of mitochondrial 
biogenesis, was downregulated in cATG3 KO mouse heart (Figure 2.3F). We also 
found the mRNA expression of other mitochondrial biogenesis markers, including 
NRF1, NRF2 and TFAM, was all decreased in ATG3-deficient heart (data not shown). 
Thus impaired mitochondrial biogenesis may account for mitochondrial content loss in 






Mitochondrial dysfunction precedes age-dependent cardiac  
contractile dysfunction in cATG3 KO mice 
We monitored cardiac function in a cohort of cATG3 KO mice and their WT 
littermates after birth. Cardiac dysfunction occurred in cATG3 KO mice at as early as 4 
weeks old, while at 1 week and 2 weeks after birth, cardiac function in cATG3 KO mice 
was preserved (Figure 2.S2A). We then harvested heart tissues from 1-week-old and 4-
week-old cATG3 KO mice and their WT littermates. We found reduced citrate synthesis 
activity and decreased mitochondrial complexes at 1-week-old cATG3 KO mice, when 
cardiac function is normal (Figure 2.S2B,C), suggesting mitochondrial dysfunction 
precedes heart failure in cATG3 KO mice.  
Moreover, we conducted metabolomics analysis for metabolic intermediates in 
1-week-old and 4-week-old mouse heart samples. Most of the tricarboxylic acid (TCA) 
cycle intermediates, including succinic acid and malic acid, were significantly reduced in 
cATG3 KO mice heart at 1 week old (Figure 2.S2D). These results indicate metabolic 
flux to TCA was partially blocked in 1-week-old ATG3-deficient heart, suggestive of 
inhibited mitochondrial function. 
Blocked glycolytic flux and decreased GAPDH activity  
in ATG3-deficient hearts 
We further investigated the mechanism by which autophagy modulates 
mitochondrial function guided by the data generated from metabolomics. We first 
measured amino acid concentrations in cardiac extracts in 1-week-old and 4-week-old 
mice. Contrary to the previously reported findings in livers, we did not observe any 
change in amino acid levels from cATG3 KO mouse heart at 1 week and 4 weeks of 
age (Table 2.3). Surprisingly, we found the glucose metabolism was dramatically 






compared to age-matched WT control mouse heart, there was a two-fold increase in 
glucose-6-phosphate in 1-week-old and five-fold increase in 4-week-old ATG3-deficient 
heart. The accumulation of glycolytic intermediates suggests the existence of a switch 
in substrate utilization for energy production in ATG3-deficient hearts, with a preference 
for glucose rather than fatty acid [30]. More interestingly, we noticed that the 
accumulated glycolytic intermediates were over-represeted by those in the early stages 
of glycolysis, whereas downstream intermediates were unchanged or even reduced 
(Figure 2.S3).  
To further investigate the mechanism by which glycolytic pathway was blocked 
in ATG3-deficient heart, we found the glycolysis was blocked in the step catalyzed by 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). GAPDH is an NAD-
dependent enzyme that catalyzes the sixth step of glycolysis [31], and inhibited GAPDH 
activity could reduce glycolytic flux and lead to accumulation of early stage 
intermediates. Indeed, we found that GAPDH activity in cATG3 KO mice hearts were 
significantly decreased (Figure 2.S4A) without any changes in expression level (Figure 
2.S4B). Supplying exogenous NAD+ (10mM) was sufficient to normalize GAPDH 
activity in ATG3-deficient hearts (Figure 2.S4A), suggesting that NAD+ depletion might 
account for the inhibited GAPDH activity and impaired glycolytic flux in cATG3 KO mice 
hearts. Moreover, we also demonstrated that total protein acetylation in cATG3 KO 
mice heart was increased (Figure 2.S4C). This difference was unlikely due to the 
increased acetyl-CoA levels, since there was a trend towards decreased acetyl-CoA in 
cATG3 KO mice hearts (Figure 2.S4D). Sirtuins (SIRT) are a class of proteins that 
possess deacetylase activity that regulate various metabolic processes in a NAD+-
dependent manner [32]. Two of the known downstream acetylated target proteins of 
SIRT1, FOXO1 and PGC1α [33], were hyperacetylated in cATG3 KO mice hearts 







Altered NAD+ metabolic flux in cATG3 KO mouse hearts 
Based on the observation of decreased GAPDH activity and increased protein 
acetylation in cATG3 KO mouse hearts, we hypothesized that NAD+ metabolism may 
be altered in cATG3 KO mouse hearts. We therefore measured NAD+ and its 
metabolites under basal conditions or after 7 days of nicotinamide riboside (NR) 
treatment. Although cATG3 KO mice exhibited unchanged NAD+ content in the heart 
under basal conditions, they showed significantly lower cardiac NAD+ levels following 
NR supplementation, suggestive of altered NAD+ metabolic rate (Figure 2.4A).  
Besides NAD+ , cATG3 KO mice also exhibited reduced NAD+ related 
metabolites, including nicotinamide acid mononucleotide (NAMN), nicotinic acid 
riboside (NAR), nicotinamide adenine dinucleotide (NAAD), nicotinamide 
mononucleotide (NMN) and nicotinamide (NAM) after NR administration (Table 2.4). On 
the contrary, NAD+ degradation products, including methylated-nicotinamide (MeNAM), 
Me-4PY and Me-2PY (Figure 2.4B), showed a trend towards increase in cATG3 KO 
mouse hearts after NR administration.  
To further investigate NAD+ metabolism in cATG3 KO mouse hearts, we used 
isotope-labeled NR to determine NAD+ metabolic flux (Figure 2.4C). Consistent with 
our earlier findings in NR administration, ATG3-deficient hearts exhibited significantly 
lower NAD+ and NAM enrichment, but higher MeNAM enrichment (Figure 2.4D,E). 
These findings are consistent with the hypothesis that NAD degradation was 
accelerated in cATG3 KO mouse heart.  We also measured the mRNA expression of 
NAD+ related enzymes, and found that NRK1, NAMPT, NMNAT3 and NNMT were 
significantly induced in cATG3 KO mouse hearts (Figure 2.4F), indicting increased 






Induced NNMT when autophagy inhibited in cardiomyocytes 
Nicotinamide N-Methyltransferase (NNMT) is the enzyme for converting NAM to 
MeNAM in NAD+ metabolism [34]. Since we observed increased MeNAM production 
following NR administration and more labeled MeNAM enrichment in cATG3 KO mouse 
heart (Figure 2.S5B,E), we hypothesized NNMT might be induced in ATG3-deficinet 
heart, which may contribute to altered NAD+ metabolism and affects cardiac function. 
 Indeed, we found that NNMT protein levels were increased in cATG3 KO 
mouse hearts relative to WT mouse hearts (Figure 2.S5A). In addition to mice with 
constitutive cATG3 KO, we also generated inducible cardiac-specific ATG3 KO mice 
using a tamoxifen-inducible Mer-Cre-Mer cardiiomyocyte-restricted transgene [35]. In 
cardiac inducible ATG3 knockout (CIATG3 KO) mice, we found decreased ATG3 
expression and autophagy inhibition 1 week after tamoxifen injection (Figure 2.S5B). 
Interestingly, although cardiac function was preserved at this time point (data not 
shown), CIATG3 KO mice exhibited significantly increased NNMT expression in their 
hearts (Figure 2.S5B), suggesting that NNMT accumulation may be an early event 
before heart failure in autophagy-deficient hearts. 
To further study whether NNMT induction is directly mediated by an ATG3 
dependent pathway or is secondary to the change in autophagy, we applied 
pharmacological approaches to inhibit autophagic flux in the heart using colchicine (Col) 
and chloroquine (CQ) respectively [36] [37]. Blocked autophagic flux with Col or CQ in 
WT mice led to NNMT accumulation in the hearts relative to PBS treated controls 
(Figure 2.S5C,D). With ATG3 gene knockdown, autophagy was inhibited and NNMT 
protein expression was induced (Figure 2.S5E). Similarly, blocking autophagy by ATG5 






NNMT overexpression caused NAD+ depletion and repressed  
mitochondrial respiration in cardiomyocytes 
Our data indicated that autophagy inhibition may precipitate NNMT 
accumulation in cardiomyocytes. To further elucidate the role of NNMT in 
cardiomyocytes, we overexpressed NNMT in H9C2 cells using an adenovirus vector 
harboring NNMT cDNA and used ad-GFP as control. Compared to ad-GFP controls, 
following NNMT overexpression in H9C2 cells (Figure 2.5A), cellular NAD+ and 
nicotinamide (NAM) levels were both significantly reduced, and the NAD+ metabolite 
MeNAM was highly accumulated (Figure 2.5B). 
Since NNMT is specifically localized in the mitochondrial fraction of hearts and 
H9C2 cells (Figure 2.5C), we hypothesized that NNMT induction exerts some effects on 
mitochondrial function. Indeed, NNMT overexpression impaired mitochondrial 
respiration under both basal and FCCP-stimulated conditions (Figure 2.5D).  
NNMT inhibition normalized mitochondrial dysfunction in the 
autophagy deficient cardiomyocytes 
ATG3 silencing inhibited autophagy and reduced mitochondrial respiration in 
cultured H9C2 cells (Figure 2.S5E, Figure 2.6A). Interestingly, we observed that NNMT 
silencing was sufficient to rescue mitochondrial dysfunction in ATG3 knockdown cells 
(Figure 2.6B,C), suggesting that the adverse effect of ATG3 deletion in mitochondrial 
function may be NNMT dependent.  
Similarly, CQ, the autophagy inhibitor, reduced autophagic flux and increased 
NNMT protein expression in cultured H9C2 cells (Figure 2.6D). Consistent with the 
NNMT accumulation, CQ treatment led to NAM depletion and MeNAM accumulation in 
H9C2 cells, suggestive of increased NNMT activity in CQ-treated cells (Figure 2.6E). 






mitochondrial dysfunction in H9C2 cells (Figure 2.6F). These data revealed that 
mitochondrial dysfunction in autophagy deficient cells might be through NNMT 
dependent manner.     
NMN increased cardiac NAD+ content and restored cardiac  
contractile function in cATG3 KO mice 
Nicotinamide mononucleotide (NMN) is an intermediate of the NAD+ 
biosynthesis pathway and is found to be protective in hearts by increasing cardiac 
NAD+ content [13, 16]. After 7 days of NMN i.p. injection, the autophagy defect in 
cATG3 KO mouse hearts was unchanged (Figure 2.7A). However, NAD+ and its 
metabolites, including NADH, NADP+ and NADPH, were also significantly increased in 
WT and cATG3 KO mouse hearts (Figure 2.7B). Consistent with increased NAD+ 
content following NMN administration, NMN normalized protein hyperacetylation of 
FOXO1 in cATG3 KO mice hearts (Figure 2.7C). Citrate synthesis activity was also 
restored in cATG3 KO mouse hearts, suggestive of improved mitochondrial function 
(Figure 2.7D). Importantly, cardiac dysfunction in cATG3 KO mice was completely 
rescued after NMN supplementation (Figure 2.7E).  
The mitochondrial biogenesis defect was not rescued by NMN treatment in 
cATG3 KO mice heart. Instead, NMN reduced mitochondrial biogenesis in both WT and 
cATG3 KO mice hearts, as evidenced by reduced mtDNA copy number, suggesting 
NMN may have adverse effect on mitochondrial biogenesis in the heart (Figure 2.7F,G).  
Discussion 
The present study revealed an essential role of autophagy in maintaining 
cardiac function by generating cardiac-specific ATG3 deficient mice. We compared 
bioenergetics of hearts in cATG3 KO mice and WT mice. We found that cATG3-






production. Moreover, we demonstrated that mitochondrial dysfunction precipitated by 
ATG3 deletion precedes cardiac contractile dysfunction, suggesting a critical role for 
mitochondrial dysfunction in heart failure development in this model. We also found that 
when ATG3 was deleted in vitro, mitochondria in cardiomyocytes became 
dysfunctional, characterized by decreased oxygen consumption rate, suggesting that 
autophagy may modulate mitochondrial function in a cell-autonomous manner. This is 
consistent with earlier findings in ATG7 KO MEFs, which exhibited reduced oxygen 
consumption rate relative to WT MEFs [38]. Our in vivo and in vitro data further confirm 
that autophagy deficiency impairs mitochondrial function in cardiomyocytes. 
It is widely accepted that autophagy might play a role in mitochondrial function 
maintenance [19], but the exact mechanism is still unclear. One proposed mechanism 
is that autophagy may function to clear dysfunctional mitochondria to maintain its 
quality. In the previously generated ATG5 KO mice, ATG5-deficient hearts showed 
disorganized sarcomeric structure and mitochondrial alignment both in adult  and 
developing hearts [3] [4]. We indeed found that ATG3-deficient hearts showed 
abnormal mitochondrial morphology and reduced mitochondrial content, which may 
contribute to the decreased mitochondrial function.  
There is a change in the cardiac metabolic substrate preference from 
carbohydrates to fatty acids during the perinatal period, but the mechanism of this 
transition are incompletely understood. Interestingly, our studies revealed that cATG3-
deficient hearts exhibited impaired mitochondrial biogenesis and altered substrate 
preference since the age of 1 week. Autophagy is thought to be involved in 
mitochondrial quality control by clearing damaged mitochondria through lysosomal 
pathways, but its role in regulating mitochondrial biogenesis is incompletely understood. 
Here, for the first time we demonstrate that intact autophagy could be a prerequisite for 






There is a burst of mitochondrial biogenesis gene induction, such as PGC1α, 
NRF1 and NRF2, in the heart after birth, which may mediate the metabolic switch from 
glucose to fatty acids as the predominant energy substrate in the maturing heart [39]. 
We also observed impaired mitochondrial substrate metabolism and accumulation of 
glucose metabolites in heart tissue, suggesting that ATG3-deficient hearts could be 
more reliant on glucose as its main substrate, potentially as a consequence of impaired 
mitochondrial biogenesis. Consistent with our study, a recent study found mitophagy 
defective hearts showed a similar inhibition in metabolic transition in perinatal hearts, 
characterized by reduced mitochondrial biogenesis and impaired fatty acid metabolism 
[40]. Thus autophagy may play an essential in promoting mitochondrial biogenesis and 
regulating metabolic switch process in perinatal hearts.  
Importantly, our results revealed that autophagy is involved in the regulation of 
NAD+ metabolism in cardiomyocytes. NAD+ functions as the most important electron 
carrier used in oxidative phosphorylation for cardiac fuel supply [41], and impaired 
myocardial NAD+ metabolism has been implicated in  cardiomyopathy [42] [13]. Our 
findings revealed that, although the NAD+ level was not depleted, NAD+ metabolic flux 
was increased in ATG3-deficient heart, which is also accompanied by increased protein 
acetylation. In failing cardiac tissue from heart failure patients, there were increased 
levels of acetylated mitochondrial proteins. Moreover, elevated levels of mitochondrial 
protein acetylation were detected at the earliest stages of heart failure in animal models 
[43]. Therefore, it is important to illustrate how protein hyperacetylation contributes to 
heart failure in our model in future studies.    
Sirtuin (SIRT) family may connect NAD+ homeostasis to protein acetylation and 
mitochondrial function in the heart. Among seven sirtuins family proteins, SIRT1 is a 
NAD-dependent deacetylase that removes acetyl groups from various proteins, and 






Thus we hypothesized that ATG3-deficient hearts may exhibit impaired mitochondrial 
biogenesis in a NAD+-SIRT1 dependent manner. For this reason, we supplemented 
cATG3 KO mice with NMN, a precursor of NAD+ in the heart [13]. Although NAD+ 
content was increased and Foxo1 hyperacetylation normalized in ATG3-deficient 
hearts, which could be expected to be associated with improved SIRT1 activity, we did 
not observe a rescue of the mitochondrial biogenesis defect in ATG3-deficient hearts. 
Indeed, we found that NMN decreased mitochondrial biogenesis and reduced 
mitochondrial content in WT mice hearts. These results are consistent with a recent 
finding that SIRT1 overexpression in rat triceps muscle resulted in impaired 
mitochondrial biogenesis and decreased expression of mitochondrial proteins, rather 
than their expected improvement of mitochondrial biogenesis [45]. The detailed 
mechanism is still unclear so far, but these results, at least, might lead to a re-
examination of the role of NAD+ and SIRT1 in mitochondrial biogenesis in the heart.  
Nicotinamide N-methyltransferase (NNMT) is the enzyme that converts 
nicotinamide (NAM) to 1-methyl-nicotinamide (MeNAM), which is further degraded and 
cleared from tissues [46] [47]. NNMT expression levels are altered in various disease 
conditions, for example, NNMT is increased in lung cells with non-small lung cancer 
[48], in neurons in Parkinson’s diseases [49], as well as in adipocytes in subjects with 
obesity and type 2 diabetes s [50], [51]. We observed NNMT mRNA and protein 
expression levels were induced in ATG3-deficient hearts as well as in the hearts of 
mice in which autophagy was inhibited. We also independently observed this in other 
autophagy deficient animal models, such as  cardiac-specific inducible ATG3 KO mice 
and following colchicine and chloroquine treatment  [52]. These results indicate that 
NNMT induction might be a common response to autophagy inhibition in 
cardiomyocytes. But the molecular mechanism by which NNMT induction in autophagy 






significantly increased in ATG3 SiRNA treated or CQ-treated H9C2 cells (data not 
shown), indicating NNMT induction by autophagy inhibition may be in transcriptional 
level. These results were consistent with the previous finding in type 2 diabetic animal 
models, where NNMT mRNA was upregulated in liver and adipose tissue. In future 
studies, NNMT promoter reporter construct may facilitate the screen of potential 
transcriptional factors which connects NNMT transcription and autophagy. 
We then investigated the role of NNMT in the regulation of cardiomyocyte 
metabolism. Earlier studies observed that NNMT knockdown increased NAD+ content 
and oxygen consumption in in rat adipocytes [53], but its role in cardiomyocytes was not 
previously studied. When NNMT was overexpressed in cultured cardiomyocytes, we 
found that NNMT overexpression caused cellular NAD+ pool depletion and increased 
cellular nicotinamide methylation and clearance. Importantly, we identified NNMT as a 
mitochondria-localized protein. NNMT overexpression impaired mitochondrial 
respiration and led to a switch from mitochondrial respiration to glycolysis in cultured 
cardiomyocytes. This metabolic switch is consistent with our in vivo observations in 
cATG3 KO mouse hearts. It raised the possibility that NNMT induction in autophagy-
deficient cardiomyocytes may contribute to impaired mitochondrial respiration leading to 
a metabolic switch towards glycolysis as the predominant fuel supply in these 
cardiomyocytes. 
The detailed mechanism by which NNMT modulates mitochondrial function is 
incompletely understood. In a recent study, supplementation of high-fat diet with NNMT 
inhibitor MeNAM decreased serum and liver cholesterol and liver triglyceride levels in 
mice [20], suggesting the involvement of NNMT in metabolic diseases, but the role of 
NNMT in mitochondria was never investigated before. With NNMT knockdown or using 
the NNMT inhibitor MeNAM, we were able to blunt the adverse effect on mitochondrial 






These results suggest that NNMT induction may contribute importantly to mitochondrial 
dysfunction when autophagy is inhibited.  
Here we describe a novel NAD+ regulation pathway by autophagy. Under 
nutrient starvation, autophagy is induced as a well-known stress response to degrade 
proteins and organelles to provide energy. In addition to this well-established role, 
increased autophagy also enhanced cellular NAD+ content by downregulating NNMT 
expression and preventing NAD+ degradation. This altered NAD+ metabolism may 
trigger certain biological signaling and function as a cellular survival mechanism when 
nutrient is deprived.   
Finally, we replenished cardiac NAD+ levels using its precursor NMN, and we 
found that mitochondrial dysfunction and cardiac contractile dysfunction were 
completely rescued in cATG3 KO mice hearts, suggesting that altered NAD+ 
metabolism could be an important cause of heart failure in ATG3-deficient hearts. 
Although mitochondrial function was improved after NMN treatment, the defect in 
mitochondrial biogenesis in cATG3 KO mice hearts was not prevented. It is likely that a 
mechanism other than NAD+ might be responsible for the link between autophagy and 
mitochondrial biogenesis in the heart. In summary, our results showed that ATG3 
deletion in the heart impaired cardiac autophagy, which induced NNMT and increased 
NAD+ catabolism. As a consequence, cardiac mitochondria became dysfunctional and 
cardiac contractile function was impaired. These results render NNMT and NAD+ flux a 
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Figure 2.1 Cardiac specific ATG3 deletion blocks autophagic flux in 4-month-old 
mouse hearts. (A) Genotyping of ATG3 flox/flox and alpha-MHC CRE. (B) ATG3 
protein content in whole heart lysates from WT and cATG3 KO mice, n=3. (C) LC3 and 
p62 protein content in WT, cATG3 heterozygous and cATG3 KO hearts, n=3. (D) LC3 
and p62 protein content in liver, skeletal muscle, adipose tissue and kidney from WT 
and cATG3 KO mice, n=2. (E) LC3 and p62 levels were measured in WT and ATG3-
deficient heart under random-fed conditions or after 48 h starvation, n=4. **p<0.01, 








Figure 2.2 cATG3 KO developed cardiac contractile dysfunction in the absence of 
histological changes at 4 months old. (A) Fractional shortening in WT and cATG3 
KO male and female mice measured by echocardiography under anesthesia with 
isoflurane, n=6-8. (B) Fractional shortening in WT and cATG3 KO mice under random-
fed conditions or after 48 hours starvation, n=4. (C) ANP and BNP mRNA expression 
levels in WT and ATG3-deficient hearts, n=6. (D) Representative H&E staining and 
trichrome staining in WT mice and cATG3 KO mice hearts, n=3. (E) Representative 










Figure 2.S1 Fatty acid oxidation was repressed in 4-month-old ATG3-deficient 
hearts. (A) mRNA levels of transcripts encoding fatty acid beta oxidation proteins in WT 
and ATG3-deficient hearts, n=6. (B) Carnitine palmitoyltransferase (CPT) activity was 
determined in isolated cardiac mitochondria from WT and cATG3 KO mice, n=6. (C) 
Triglyceride levels were measured in WT and ATG3-deficient hearts under random-fed 
conditions or after 48 hours of starvation, n=4. (D) Representative oil red O staining of 
frozen sections from WT and cATG3 KO mice hearts, n=3. **p<0.01, *p<0.05 versus 










Figure 2.3 Mitochondrial function was decreased in 4-month-old ATG3-deficient 
hearts. (A) Oxygen consumption rate was measured in WT and cATG3 KO mouse 
hearts fibers, n=6. (B) ATP production rate was measured in cardiac fibers following 
stimulation with ADP, n=6. (C) Citrate synthase activity was measured in WT and 
cATG3 KO mice hearts, n=6. (D) Mitochondrial electron transport complex expression 
in WT and ATG3-deficient heart, n=3. (E) Mitochondrial morphology and structure in 
WT and ATG-deficient heart sections by transmission electron microscopy, n=5. (F) 
PGC-1α protein levels in WT and cATG3 KO mice hearts, n=3. **p<0.01, *p<0.05 when 










Figure 2.S2 Cardiac mitochondrial dysfunction precedes cardiac dysfunction in 
cATG3 KO mice. (A) Fractional shortening at 1 week, 2 weeks and 4 weeks of age in 
WT and cATG3 KO mice, n=3-6. (B) Citrate synthase activity in 1-week-old, 2-week-old 
and 4-week-old WT and cATG3 KO mouse hearts, n=6. (C) PGC-1α and mitochondrial 
complex expression levels were measured in 1-week-old and 4-week-old WT and 
ATG3-deficient hearts, n=2. (D) Tricarboxylic acid cycle (TCA cycle) intermediates in 1-
week-old and 4-week-old ATG3 KO mouse hearts, shown as fold change compared to 











Figure 2.S3 Glycolytic intermediates in 1-week-old and 4-week-old WT and ATG3-
deficient hearts. All metabolites were measured using GC-MS, n-5-6. **p<0.01, 












Figure 2.S4 cATG3 KO mice exhibited protein hyperacetylation in mouse heart at 
4 weeks. (A) GADPH activity measurement in WT and ATG3-deficient hearts without or 
with exogenous NAD+ supplementation, n=6. (B) GADPH protein levels in WT and 
ATG3-deficient hearts, n=3. (C) Total protein acetylation in WT and ATG3-deficient 
hearts, n=3. (D) Acetyl-CoA, Succinyl-CoA and malonyl-CoA levels in WT and ATG3-
deficient hearts, n=3-5. (E) Foxo1 and Ac-Foxo1 expression levels in WT and ATG3-
deficient hearts, n=3. (F) PGC-1α acetylation in WT and ATG-deficient hearts using Co-










Figure 2.4 NAD+ metabolism was altered in cATG3 KO mouse heart at 6 weeks. 
(A) NAD+ content was measured in WT and ATG3-deficient hearts after PBS or 
Nicotinamide riboside (NR) administration, n=6. (B) Measurement of NAD+ breakdown 
products, including MeNAM, Me-2PY and Me-4PY in WT and ATG3-deficient hearts 
after PBS or NR administration, n=6. (C) Schematic depicting use of isotope-labeled NR 
to trace NAD+ metabolism in the heart. (D) NAD+ enrichment in WT and ATG3-deficient 
hearts at 0, 30 min and 60 min after isotope-labeled NR injection, n=4. (E) Me-NAM 
enrichment in WT and ATG3-deficient hearts at 0, 30 min and 60 min after isotope-
labeled NR injection, n=4. (F) NAD+ related enzyme mRNA expression levels in WT and 










Figure 2.S5 Autophagy inhibition induces NNMT accumulation in cardiomyocytes 
in vivo and in vitro. (A) ATG3, LC3 and NNMT protein levels in WT and cATG3 KO 
mouse hearts, n=3. (B) ATG3, LC3 and NNMT protein levels in WT and inducible ATG3 
KO mouse hearts 1 week after tamoxifen injection, n=3. (C) LC3 and NNMT expression 
protein in PBS or Colchicine (Col) treated hearts, n=3. (D) LC3 and NNMT protein 
levels in PBS or Chloroquine (CQ) treated hearts, n=3. (E) ATG3, LC3, p62 and NNMT 
expression in ATG3 SiRNA treated H9C2 cells, n=3. Scrambled SiRNA was used as 
control, n=3. (F) ATG5, LC3 and NNMT protein expression in ATG5 SiRNA treated 










Figure 2.5 NNMT overexpression depletes NAM and represses mitochondrial 
respiration in cultured cardiomyocytes. (A) NNMT expression following adenoviral 
transfection of GFP or NNMT in cultured H9C2 cells, n=3. (B) Measurement of NAD+, 
nicotinamide (NAM) and MeNAM in ad-GFP or ad-NNMT transfected H9C2 cells, n=6. 
(C) Detection of NNMT expression in cytosolic or mitochondrial fraction from WT hearts. 
(D) Oxygen consumption rates in ad-GFP or ad-NNMT transfected H9C2 cells, n=6-8. 









Figure 2.6 NNMT inhibition prevented mitochondrial dysfunction induced by 
autophagy inhibition in cultured cardiomyocytes. (A) Oxygen consumption rate 
measurement in ATG3 SiRNA treated H9C2 cells. Scrambled SiRNA was used as 
control, n=6-8. (B) NNMT, ATG3 and LC3 expression in ATG3, NNMT and double 
knockdown H9C2 cells. Scrambled SiRNA was used as control, n=2. (C) Oxygen 
consumption rate measurement in control, ATG3 knockdown and double knockdown 
H9C2 cells, n=5-6. (D) LC3 and NNMT expression in PBS or CQ treated H9C2 cells. 
H9C2 cells were treated with 80 µM CQ for 24 or 48 hours, and subjected to 3 hours 
HBSS starvation before harvest, n=3. (E) NAD+, NAM and MeNAM measurement in CQ 
treated H9C2 cells. H9C2 cells were treated with 20 µM CQ for 24 or 48 hours, and 
subject to 3 hours HBSS starvation before harvest. PBS treatment was used as control, 
n=3. (F) Oxygen consumption rate measurement in control, CQ or CQ with MeNAM 








Figure 2.7 NMN increased cardiac NAD+ content and rescued cardiac contractile 
dysfunction in 4-week-old cATG3 KO mice. (A) LC3 and p62 expression levels in 
PBS or NMN-treated hearts from WT and cATG3 KO mouse hearts, n=5-6. (B) 
Bioenergetics metabolites measurement in PBS or NMN-treated WT and cATG3 KO 
mice, n=4-6. (B) Ac-Foxo1 expression levels in whole heart lysates, n=3. (D) Citrate 
synthase activity measurement in WT and cATG3 KO mouse hearts, n=6. (E) Fractional 
shortening in WT and ATG3-deficient hearts after PBS or NMN treatment, n=6. (F) 
mtDNA copy number in PBS or NMN-treated hearts from WT and cATG3 KO mice 
heart, n=6. (G) Mitochondrial-related nuclear mRNA expression in WT and cATG3 KO 
mice heart following PBS or NMN administration for 7 days, n=6. **p<0.01, *p<0.05 






Table 2.1 Primer sequences for RT-qPCR. 
 
 
Gene Forward Reverse 
RPL13a CTCTGGCCTTTTCCTTTTTG CCGAAGAAGGGAGACAGTTC 
NNMT GATTGCACGCCTCAACTTCT GAACCAGGAGCCTTTGACTG 
NMRK1 CTTGAAGCTTGCTCTGCGAC CTCCGTTTGTCACACCACCA 
NMRK2 AAGCCCCAGGACCAAATAGC GCGTGCAAACTTGTGTGGAT 
PARP1 CACCTTCCAGAAGCAGGAGA GCAGCGAGAGTATTCCCAAG 
SIRT1 GACACAGAGACGGCTGGAAC CAGACCCTCAAGCCATGTTT 
NMAPT TCACGGCATTCAAAGTAGGA GCAGAAGCCGAGTTCAACAT 
NMNAT3 CAGAAGCACCACAGGGATTC CCTGCAGCACGTTTACAGTC 
NMNAT2 ATCCCGCCAATCACAATAAA GCAGCTTCAATCCCATCACT 
NMNAT1 TGAGTCCATGGGGAGAAGTT AGGACTAGGGCCGTTTGG 
SOD1 CGGCGGATGAAGAGAGGCA TCACACGATCTTC 
AATGGACACA 
Catalase GCAGATACCTGTGAACTGTC GTAGAATGTCCGCACCTGAG 
ANP ATGGGCTCCTTCTCCATCA CCTGCTTCCTCAGTCTGCTC 
BNP GGATCTCCTGAAGGTGCTGT TTCTTTTGTGAGGCCTTGGT 
ATG3 ATCTGTTTCCAACAATCCAC GAGTATTCGGATGAATTGGA 
Cyto-C ATCTCCACGGTCTGTTCGGG TCCCCAGGTGATGCCTTTGT 
PGC-1 GTAAATCTGCGGGATGATGG AGCAGGGTCAAATCGTCTG 













Table 2.2 Heart weight and heart weight/tibia length in 4-week-old and 4-month-
old mice. **p<0.01, *p<0.05 when compared WT mice, n=12-16. 
 
Age  WT cATG3 KO 
4 Weeks Heart weight (mg) 88.36 ± 2.96 94.10 ±3.46 
Heart weight/Tibia length (mg/mm) 4.88 ± 0.18 5.30± 0.10* 
4 months Heart weight (mg) 112.16± 2.73 126.15± 3.31** 







Table 2.3 Amino acid levels in 1-week-old and 4-week-old cATG3 KO mouse 
hearts. The relative change of each amino acid in ATG3-deificient hearts is 
represented as the fold changed compared to their aged matched WT mice. **p<0.01, 
*p<0.05 when compared WT mice, n=6. 
 
Amino acid 1 week 4 weeks 
Mean SE Mean SE 
lysine 0.88 0.06 0.74 0.09 
valine 1.08 0.04 1.03 0.05 
leucine 1.04 0.03 0.86 0.02 
isoleucine 1.06 0.05 1.05 0.05 
threonine 0.99 0.04 1.08 0.05 
homoserine 0.94 0.05 1.14 0.05 
glycine 0.94 0.05 1.14 0.05 
serine 0.79 0.10 1.76 0.41 
alanine 0.87 0.04 0.87 0.06 
glutamic acid 1.18 0.05 0.88 0.04 
glutamine 0.98 0.06 0.92 0.07 
proline 0.96 0.09 0.85 0.10 
aspartic acid 1.04 0.08 0.87 0.09 
asparagine 1.11 0.09 1.02 0.08 
methionine 0.96 0.02 0.98 0.08 
cysteine 1.06 0.24 1.79* 0.38 
homocysteine 0.99 0.18 0.92 0.17 
phenylalanine 0.97 0.03 0.92 0.04 
tyrosine 0.98 0.09 1.04 0.05 
tryptophan 1.02 0.02 0.90 0.08 
histidine 0.78 0.04 0.66 0.07 
N-methylalanine 1.04 0.03 1.43 0.20 
sarcosine 0.96 0.08 0.80 0.15 
4-hydroxyproline 1.02 0.19 0.83 0.14 
ornithine 0.91 0.07 1.03 0.07 
N-acetylaspartate 1.48* 0.16 1.19 0.30 








Table 2.4 NAD+ related metabolites in WT and cATG3 KO mouse hearts after PBS 





WT-PBS KO-PBS WT-NR KO-NR 
Mean SE Mean SE Mean SE Mean SE 
NADP 21 1.2 20 1.4 22 4.2 20 1.4 
NAAD 0.1 0.02 0.15 0.07 21## 4.3 13## 3.2 
NMN 0.77 0.04 0.76 0.09 1.7## 0.23 1.1## 0.15 
NAR 0.02 0.01 0.01 0.01 0.15## 0.01 0.08 0.01 
ADPR 10 1.4 12 2.2 11 1.6 8.8 1.1 
NAMN NA NA NA NA 0.78 0.06 0.51 0.08 
Uridine 2.5 0.61 3.9 1.7 2.9 0.84 1.9 0.45 
Cytidine 2.8 0.92 2.7 1.4 2.4 0.56 1.8 0.32 
Inosine 1.8 0.68 11 4.9 3.8 2 1.2 0.21 








Table 2.5 Sequence for SiRNA. 
 





ATG5 AUCUGAGCUAUCCAGACAA UUGUCUGGAUAGCUCAGAU 
Control UAAGGCUAUGAAGAGAUAC GUAUCUCUUCAUAGCCUUA 
ATG3 GGUGUUCAUAUGUAUCUUUTT   AAAGAUACAUAUGAACACCAA 





              




AUTOPHAGY IS REQUIRED FOR IMPROVING CARDIAC  
PERFORMANCE FOLLOWING EXERCISE 
Abstract 
Autophagy is an evolutionarily conserved catabolic process that degrades 
proteins and organelles to maintain cellular homeostasis. Recent studies showed that 
exercise training induces autophagy in the heart; however, it is still unclear how 
exercise-induced autophagy regulates cardiovascular function. In this study, we 
investigated the role of autophagy in cardiac function using wild-type (WT) mice and 
beclin 1 heterozygous mice following 6 weeks of treadmill training. After exercise 
training, beclin 1 heterozygous mice showed impaired autophagy relative to WT mice. 
As a consequence, although exhibiting similar cardiac hypertrophic responses, cardiac 
function improvement and enhanced mitochondrial oxidative capacity were blunted in 
beclin 1 heterozygous mice after 6 weeks of chronic training. Exercise-induced 
mitochondrial biogenesis was prevented in beclin 1 heterozygous mice, which may be 
due to the impaired AMPK activation in autophagy deficient hearts. Moreover, beclin 1 
heterozygous mice showed impaired anti-oxidant gene expression and increased ROS 
production in response to exercise training. Thus, autophagy may promote cardiac 
mitochondrial biogenesis, increase cardiac mitochondrial function, decrease ROS 








Autophagy is an essential process by which cells break down their own 
components to maintain cellular homeostasis [1, 2]. In this process, certain long-lived 
proteins, damaged organelles and malformed proteins are degraded and recycled by the 
lysosomes. Autophagy has been implicated in various cardiovascular diseases, such as 
ischemia/reperfusion, pressure-overload induced cardiomyopathy as well as chronic 
heart failure [3] [1]. 
Exercise, particularly endurance exercise training, improves cardiac function in 
health and disease conditions [4]. For instance, in a large and prospective study, 
exercise training shows significant beneficial effect for old patients with coronary artery 
disease and heart failure [5]. Exercise mediates benefits not only by reducing 
cardiovascular risk factors, such as diabetes or hypertension, but also by directly 
improving cardiac function  [6] [7, 8].  One beneficial effect of endurance exercise 
training in the heart is by increasing cardiac energy metabolism [9] [10], but detailed 
mechanism by which exercise increases cardiac bioenergetics and maintains cardiac 
function is incompletely understood. 
Exercise was recently reported to induce autophagy in skeletal muscle and 
cardiac muscle [11], and this study revealed an essential role of autophagy in regulating 
skeletal muscle glucose homeostasis. However, the mechanisms by which exercise-
induced autophagy improves cardiac performance or reduces cardiac injury were not 
pursued. In the present study, we observed that beclin 1 heterozygous mice did not 
induce autophagy in response to exercise, and exhibited blunted improvement in cardiac 
function and mitochondrial oxidative capacity after endurance exercise training, which 
may be due to in part to impaired AMPK activation and reduced mitochondrial 
biogenesis. Thus these results revealed an essential role of autophagy in exercise-






Materials and Methods 
Animal experiments 
This study protocol was approved by the Institutional Animal Care and Use 
Committee of University of Utah, and the Carver College of Medicine of the University of 
Iowa.  
Acute treadmill training 
Twelve-week-old mice are acclimated to and trained on a 10-degree treadmill 
incline for 3 days. On day 1, mice were subjected to run for 5 min at 8 m/min. On day 2 
mice they were subjected to run for 5 min at 8 m/min followed by another 5 min at 10 
m/min. On day 3, mice were subjected to a speed of 17 m/min for 60 min. Mice were 
sacrificed at 60 min after last exercise training. 
Chronic treadmill exercise training 
Twelve-week-old mice were trained with 10-degree uphill incline for 60 min at an 
initial speed of 5 m/min for 5 min, followed by a speed of 10m/min for 5 min, and a final 
speed of 17 m/min for 50 min. Mice were sacrificed at 60 min after last exercise training. 
Maximum running speed and exhaustion running  
Twelve-week-old mice were subject to 10-degree uphill incline treadmill training 
at an initial speed of 5 m/min for 5 min, and were then followed by increasing speed of 2 
m/min every min, until the mice stopped running.  
Lactate measurement 
Serum lactate levels were measured using a lactate assay kit (MAK064, Sigma) 
following manufactor’s protocol. Briefly, lactate concentration was determined by an 
enzymatic assay, which results in a colorimetric (570 nm)/ fluorescent (λex = 535 







Mice were anesthetized by chloral hydrate 0.5 h after acute or chronic exercise 
training. Hearts were then immediately removed and rinsed in cold PBS before being 
snap-frozen in liquid nitrogen.  
Immunoblotting 
Total proteins were extracted from hearts or cultured H9C2 cells in a lysis buffer 
containing 50 Mm HEPES (pH 7.5), 150 mM NaCl, 10% Glycerol, 1% Triton X-100, 1.5 
mM MgCl2, 1 mM EGTA, 10 mM Na4P2O7, 100 mM NaF, and 1X Halt protease and 
phosphatase inhibitor cocktail (Thermo Scientific, Rockford, IL). Protein concentration 
was determined by a Micro BCA Protein Assay kit (Pierce). For immunoblotting, 
previously extracted proteins were resolved on SDS-PAGE and analyzed by western 
blotting using the LI-COR Odyssey Imager (LI-COR), an infrared fluorescence based 
detection system. The following primary antibodies were used for immunoblotting. LC3 
(L8918) and p62/SQSTM1 (P0067) antibodies were from purchased from Sigma (St. 
Louis, MO). GAPDH (2118) antibodies were purchased from Cell Signaling (Boston, 
MA). PGC1 α (H-300) and SIRT1 (B-10) antibodies were purchased from Santa Cruz 
(Santa Cruz,CA).  
Citrate synthesis (CS) activity measurement 
Heart tissue was homogenized on ice in homogenization buffer containing 20 
mM HEPES and 10 mM EDTA at pH 7.4. Homogenates were subjected to two freeze 
and thaw cycles to liberate CS from the mitochondrial matrix and then diluted 1:10 to an 
approximate final protein concentration of 1 μg/μl. The reaction was performed in 1 ml of 
reaction buffer containing 20 mM HEPES, 1 mM EDTA, 220 mM sucrose, 40 mM KCl, 
0.1 mM DTNB, and 0.1 mM acetyl-CoA (pH 7.4 at 25°C). The reaction was started by 






spectrophotometer. The result was normalized to protein content. 
Mitochondrial respiration in cardiac fibers  
LV subendocardial muscle fibers were used to measure mitochondrial respiration 
rates and ATP synthesis as previously described. Respiration rates were determined in 
the presence of substrate palmityl-carnitine (VO), after stimulation with 1 mM ADP 
(VADP), and after addition of 1 μg/ml of the ATP synthase inhibitor oligomycin (VOligo). 
ATP synthesis rate was measured in fibers after stimulation with 1mM ADP. 
Electron microscopy 
Cardiac tissue samples were removed and fixed in electron microscopy (EM) 
fixation buffer containing 2.5% glutaraldehyde and 1% paraformaldehyde. They were 
processed and at the University of Utah Microscopy Core. 
Echocardiography 
Mice were anesthetized with 2% isoflurane gas with an inflow rate of 1 ml/min 
and placed on a heated stage (37°C). Chest hair was then removed with a topical 
depilatory agent before the echocardiogram. Fractional shortening (in %) was calculated 
as 100 × [(LVDd − LVDs)/LVDd], where LVDd is the LV dimension at diastole and LVDs 
is the LV dimension at systole. 
Quantitative PCR 
RNA extraction and quantitative real-time PCR  were performed on total RNA 
that was extracted from heart tissue using TRIzol reagent (Invitrogen, Carlsbad, CA), 
purified with the RNeasy kit (Qiagen, Valencia, CA) and reverse transcribed. 
Quantitative real-time PCR was performed using SYBR Green I with ROX as an internal 
reference dye. The expression level was normalized to the levels of RPL13A transcript. 







Statistical analyses were performed using GraphPad Prism 6. All data are 
presented as mean ± SEM. Statistical significance (p<0.05) was determined by one-way 
ANOVA and followed by an unpaired Student’s t-test.  
Results 
Exercise-induced autophagy was impaired in beclin 1  
heterozygous mouse hearts 
Since it has been reported that beclin 1 heterozygous mice exhibited exercise 
intolerance [11], it was important to optimize the chronic exercise training protocol. We 
initially failed to find any significant difference in the maximum running speed between 
WT mice and beclin 1 heterozygous mice (Figure 3.1A). Using our chosen running 
protocol (17 m/min for 1 hour), serum lactate levels in WT and beclin 1 heterozygous 
mice were significantly lower than when they were ran to exhaustion (Figure 3.1B) . This 
indicates that WT and beclin 1 heterozygous mice were not exhausted under our chosen 
chronic running protocol.  
After 1 hour acute exercise, beclin 1 protein expression was induced in WT 
mouse hearts, but not in beclin 1 heterozygous mouse hearts (Figure 3.1C). Moreover, 
we found that the LC3 II/I ratio, which is used as  an  index of autophagy induction, was 
increased in WT mice but blunted in beclin 1 heterozygous mice (Figure 3.1C), 
consistent with defective autophagy in beclin 1 heterozygous mouse hearts following 
exercise training. 
Exercise-induced cardiac contractile function improvement  
was blunted in beclin 1 heterozygous mice 
After 6 weeks of exercise training, WT and beclin 1 heterozygous mice showed 






between WT and beclin 1 heterozygous mice (Figure 3.2 A,B). When heart weight was 
normalized to tibia length, there was no significant difference between WT and beclin 1 
heterozygous mice, indicating an equivalent exercise-induced cardiac hypertrophic 
response (Figure 3.2 C). However, after 6 weeks of exercise training, cardiac contractile 
function, measured by fractional shortening (FS), was significantly increased in WT 
mice. However, this increased FS was largely prevented in beclin 1 heterozygous mice 
after endurance exercise training (Figure 3.2D). 
Exercise enhanced cardiac mitochondrial oxidative capacity  
in WT mice but not in beclin 1 heterozygous mice  
Mitochondria play an essential role in maintaining cardiac function [12]. We 
assessed mitochondrial function in saponin-permeabilized cardiac fibers from chronic 
exercise trained WT and beclin 1 heterozygous mice. Palmitoyl-carnitine supported 
ADP-stimulated mitochondrial oxygen consumption (VADP) and ATP production rates 
were induced in WT mouse heart fibers relative to sedentary WT hearts (Figure 3.3 A,B). 
This induction of oxygen consumption and ATP production were blunted in beclin 1 
heterozygous mouse hearts after exercise training (Figure 3.3 A,B). ATP/O ratios were 
similar in all groups, indicating that there were no differences between the groups in 
mitochondrial coupling in response to exercise training (Figure 3.3 C).  
Citrate synthase is a key enzyme in the TCA cycle and its activity is often used 
as a marker of mitochondrial function [13]. After 6 weeks of exercise training, citrate 
synthase activity was significantly induced in WT mouse hearts but not in beclin 1 
heterozygous mouse hearts, indicating impaired mitochondrial function enhancement in 






Exercise-induced mitochondrial mass increase was blunted  
in beclin 1 heterozygous mice 
We used transmission electron microscopy (TEM) to evaluate the morphology 
and structure of mitochondria in fixed heart sections. Mitochondrial size was significantly 
increased in exercised WT and beclin 1 heterozygous mice heart relative to their 
sedentary controls (Figure 3.4 A,B). Interestingly, we observed that mitochondrial 
coverage area, or mitochondrial density, was significantly lower in beclin 1 heterozygous 
mice heart when compared to WT mice heart in exercise group (Figure 3.4 C,D). Given 
the equivalence in cardiac mitochondrial size, the reduced mitochondrial density 
indicates beclin 1 heterozygous mice may have reduced mitochondrial number. 
Beclin 1 heterozygous mice showed impaired exercise-induced  
cardiac mitochondrial biogenesis  
After endurance exercise training, WT mice showed increased expression of 
nuclear-encoded genes that promote mitochondrial biogenesis, including PGC1 , 
NRF1, NFR2 and TFAM. However, the induction of these mitochondrial biogenesis 
genes was blunted in beclin 1 heterozygous mice (Figure 3.5 A). Moreover, mtDNA copy 
number, another marker of mitochondrial number, was reduced in beclin 1 heterozygous 
mice heart relative to exercise WT control mice (Figure 3.5 B).   
Beclin 1 heterozygous mice exhibited AMPK inactivation in  
the heart after chronic exercise training 
After endurance exercise training, AMPK is activated in the hearts of WT mice 
but not in beclin 1 heterozygous mouse hearts (Figure 3.6 A). Its downstream target, 
acetyl coA carboxylase (ACC), was also significantly higher in WT mouse hearts after 
exercise training, but this was totally blunted in beclin 1 heterozygous mouse hearts 






heart, was equivalently increased in WT and beclin 1 heterozygous mouse hearts 
(Figure 3.6 B), suggesting that AMPK inactivation in beclin 1 heterozygous mouse heart 
after exercise might occur via a mechanism that is independent of the ADP/ATP ratio.  
Beclin 1 heterozygous mice exhibited impaired anti-oxidant  
gene expression and increased ROS production  
Following exercise training, many anti-oxidant genes, including SOD1, SOD2, 
catalase, and UCP2, were significantly induced. It is assumed that these changes would 
minimize oxidative stress –induced cardiac damage. Interestingly, expression levels of 
anti-oxidant genes were increased in WT hearts but depressed in beclin 1 heterozygous 
mouse hearts after chronic exercise training (Figure 3.7 A), suggesting that beclin 1 
heterozygous mouse hearts may be more susceptible to oxidative stress-induced 
cardiac damage. We then measured reactive oxidative species (ROS) production in WT 
and beclin 1 heterozygous mice heart after 0, 40 min and 60 min acute treadmill 
exercise training. Relative to WT mice, beclin 1 heterozygous mice produced 
significantly more ROS in their hearts (Figure 3.7 B). 
Discussion 
The present study demonstrated that beclin 1 heterozygous knockout mice 
exhibited impaired exercise-induced autophagy in the heart, accompanied by blunted 
mitochondrial biogenesis and reduced anti-oxidant response, and did not increase 
cardiac function after chronic exercise training. These results suggest an essential role 
of autophagy in promoting mitochondrial biogenesis and modulating cardiac 
bioenergetics during exercise conditions. 
We confirmed that beclin 1 heterozygous mice were a suitable animal model to 
study exercise-induced autophagy in the heart. Beclin 1, the mammalian orthologue of 






embryonic lethal, and therefore cannot be used to model exercise training [15]. Beclin 1 
heterozygous mice, on the contrary, were viable, developed normally, but exhibited 
reduced autophagy under stress conditions [16]. As such we reasoned that this could 
represent a good model for studying the role of autophagy in the cardiac adaptations to 
exercise training. Compared to WT mouse hearts, the LC3II/I ratio in beclin 1 
heterozygous mice heart did not increase in response to exercise training, suggesting 
impaired exercise-induced autophagy in beclin 1 heterozygous mice. 
Exercise training exerts its beneficial effects on cardiac function in various 
models, including in humans, rats and mice [17] [18] [19] [20]. Consistent with these 
studies, we also found that exercise training improved cardiac performance in WT mice, 
characterized by increased left ventricular function, measured by echocardiography. 
However this enhancement in contractile function was blunted in beclin1 heterozygous 
mice, suggesting that autophagy may be an important mediator of exercise-induced 
cardiac remodeling. 
Cardiac hypertrophy is a general term that describes increased cardiac mass in 
response to exercise, which could be either physiological or pathological hypertrophy. In 
mild, early hypertrophy, cardiac myocyte contractile performance may be enhanced as a 
consequence [21]. We found that beclin 1 heterozygous mice, although showing 
impaired autophagy in the heart, exhibited a similar increase in heart weight as well as 
left ventricular posterior wall thickness after training in exercise-induced cardiac 
hypertrophy.  
Mitochondria are the main organelles for energy fuel metabolism in the heart and 
they play an essential role in regulating cardiac bioenergetics [22] [23]. We observed 
that ADP-stimulated cardiac fiber respiration and ATP production rate were induced in 
WT mouse hearts after exercise training, but not in beclin 1 heterozygous mouse hearts. 






mitochondrial function improvement, was also prevented in beclin 1 heterozygous mice. 
These data revealed that autophagy might be required for promoting mitochondrial 
biogenesis and increasing mitochondrial oxidative capacity in the heart following 
exercise training. This difference was not necessarily reflected by changes in 
mitochondrial morphology, since WT and beclin 1 heterozygous mice heart exhibited 
similar increases in mitochondrial size after exercise training. However mitochondrial 
coverage area, or mitochondrial density, was significantly lower in trained beclin 1 
heterozygous mice heart relative to their WT trained controls. Furthermore, we found 
mtDNA copy number was increased in WT mice heart in response to exercise training, 
but this increase was blunted in beclin 1 heterozygous mouse heart. Since the 
mitochondrial size was similar between WT and beclin 1 heterozygous mouse heart, the 
reduced density reflected decreased mitochondrial number in beclin 1 heterozygous 
mouse heart after exercise training.  
Interestingly, we observed that excise-induced induction of mitochondrial 
biogenesis genes, such as PGC1α, NRF1, NRF2 and TFAM, were prevented beclin 1 
heterozygous mouse hearts. Exercise-induced mitochondrial biogenesis is characterized 
by mitochondrial proliferation with increased mitochondrial mass, which contributes to 
cardiac function improvement [9]. Mitochondrial biogenesis is an adaptive response to 
stress conditions, and plays an essential role in maintaining cardiac function. 
Interestingly, we found this process was blunted in beclin 1 heterozygous mouse hearts, 
which may contribute to the attenuated mitochondrial and cardiac function improvement 
after exercise. Because mitochondrial mass is a balance between mitochondrial 
biogenesis and autophagy [24], attenuated mitochondrial biogenesis might be a 
secondary effect of autophagy deficiency in beclin 1 heterozygous mouse hearts. Our 
results are consistent with a recent study in skeletal muscle, where autophagy was 






Consistently, in a very recent publication, autophagic flux inhibitor colchicine abolished 
mitochondrial biogenesis following swimming exercise training in skeletal muscle [26]. 
These results, together with our finding in the heart, indicate autophagy may be involved 
in mitochondrial biogenesis signaling following exercise training in skeletal muscle and in 
the heart. 
To further investigate the molecular mechanism by which mitochondrial 
biogenesis was blunted in beclin 1 heterozygous mouse hearts, we measured AMP-
activated protein kinase (AMPK) phosphorylation. AMPK is an enzyme that is activated 
in response to energy stress, including fasting or exercise training [27]. Its activation is 
promotes increased expression of PGC-1α to increase mitochondrial biogenesis 
signaling in response to energy deficiency [28]. Beclin 1 heterozygous mice heart 
exhibited a blunted AMPK activation as a response to exercise training, which may be 
the potential mechanism by which mitochondrial biogenesis was impaired in beclin 1 
heterozygous heart following exercise-training. AMPK is activated in part by changes in 
the ADP/ATP ratio, NAD+-SIRT1 pathway, LKB1 phosphorylation, or by increased Ca2+ 
intracellular  flux in the heart [29]. We found that ADP/ATP ratio was equally increased in 
WT and beclin 1 heterozygous mouse heart, indicating that AMPK inactivation in beclin 1 
heterozygous mouse heart is through an ADP/ATP independent pathway. Besides 
ADP/ATP ratio, cellular NAD+ is another important factor to regulate AMPK activation. 
For instance, resveratrol, the well-known SIRT1 activator, activates AMPK in cultured 
HepG2 cells and mouse liver in SIRT1 dependent manner. And it is known that NAM, 
the SIRT1 inhibitor, downregulates SIRT1 and AMPK activity in cultured HepG2 cells 
[30]. In our previous studies in cardiac-specific ATG3 KO mice model, we found 
autophagy may regulate cardiac NAD+ homeostasis and SIRT1 activity in 
cardiomyocytes (data not shown). Therefore, future studies are required to understand 






which may be a potential mechanism by which autophagy regulates AMPK activation 
and mitochondrial biogenesis induced by exercise.  
Finally, we found that exercise-caused ROS production was increased in beclin 1 
heterozygous mouse heart when compared to WT mice. And this is consistent with the 
reduced anti-oxidant gene expression levels in beclin 1 heterozygous mouse heart. The 
molecular mechanisms by which AMPK acts to modulate cellular reactive oxidative 
species (ROS) levels is through activating FoxO1 (forkhead box O1) by phosphorylation 
at Thr (649) and increasing FoxO1-dependent transcription of anti-oxidant genes 
expression, including SOD2 and catalase [31]. This new finding in liver cells was 
consistent with our finding in beclin 1 heterozygous mouse heart following exercise 
training, with impaired AMPK activation, blunted anti-oxidant response and more ROS 
production.  
Since anti-oxidant defense plays an important role in preventing cardiac 
dysfunction under stress conditions [32], we may think this impaired anti-oxidant defense 
and increased ROS may further contribute to cardiac contractile dysfunction in beclin 1 
heterozygous mice after exercise training. To further testify the importance of anti-
oxidant response under exercise conditions, anti-oxidant reagent may be used to see 
whether cardiac function could be improved after exercise training when autophagy is 
inhibited in following studies.  
In summary, exercise-induced autophagy was impaired in beclin 1 heterozygous 
mice, accompanied by blunted mitochondrial biogenesis, increased cardiac ROS 
production and attenuated cardiac contractile improvement. This study illustrates a novel 
connection between autophagy and mitochondrial function in the heart under exercise 
conditions, probably through activating AMPK and promoting mitochondrial biogenesis. 
Moreover, we also revealed the essential role of autophagy in the cardiac adaptation to 
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Figure 3.1 Exercise-induced autophagy is impaired in Beclin 1 Het mice.  (A) The 
maximum running speed was determined with increased running speed until mice were 
exhausted, n=7-8. (B) Serum lactate levels from sedentary, after 1 hour running and in 
exhausted WT and beclin 1 heterozygous mice, n=6. (C) Protein levels of beclin 1 and 
LC3 in WT and beclin 1 heterozygous mouse hearts under sedentary conditions or 
following 60 min acute exercise training, n=3. *p<0.05 compared to sedentary mice, 










Figure 3.2 Beclin 1 heterozygous mice and WT mice exhibited equivalent cardiac 
hypertrophic response to training, but beclin 1 heterozygous mice failed to 
improve cardiac contractile function after exercise. (A) Body weight, Heart weight in 
chronic exercise trained or sedentary WT and beclin 1 heterozygous mice, n=6. (B, C) 
Heart weight, and heart weight/tibia length in chronic exercise trained or sedentary WT 
and beclin 1 heterozygous mice, n=6. (D) Fractional shortening measured in chronic 








Figure 3.3 Exercise-induced augmentation of mitochondrial respiratory capacity 
is blunted in beclin 1 heterozygous mice. (A) Oxygen consumption rate was 
measured in WT and beclin 1 heterozygous mouse heart fibers under sedentary or after 
exercise training conditions, n=6. (B-C) ATP production rate, or ATP/O ratio was 
measured in cardiac fibers following stimulation with ADP, n=6. (D) Citrate synthase 
activity in WT and beclin 1 heterozygous mouse hearts under sedentary conditions or 











Figure 3.4 Beclin 1 heterozygous mice exhibited similar increase in mitochondrial 
size but reduced mitochondrial density after exercise. (A) Representative images of 
mitochondria from sedentary or chronic trained mouse hearts, n=6. (B) Normalized 
mitochondrial size from sedentary or chronic trained mouse hearts, n=6. (C) 
Representative images of mitochondria from sedentary or chronic trained mouse 
hearts, n=6. (D) Normalized mitochondrial density in sedentary or chronic trained 










Figure 3.5 Exercise-induced mitochondrial biogenesis was impaired in beclin 1 
heterozygous mouse hearts. (A) mRNA expression of  nuclear –encoded genes that 
regulate mitochondrial biogenesis in sedentary or chronic trained mouse hearts, n=6. 
(B) mtDNA copy number measurement in sedentary or chronic trained mouse hearts, 












Figure 3.6 Exercise induced AMPK activation was impaired in beclin 1 
heterozygous mouse hearts, but in an ADP/ATP independent manner. (A) p-
AMPK, AMPK and p-ACC levels in sedentary or chronic trained mouse hearts, n=3. (B) 
ADP/ATP ratio was measured in sedentary or chronically trained mouse hearts, n=3. 











Figure 3.7 Cardiac anti-oxidation response was impaired in beclin 1 heterozygous 
mouse heart as response to exercise training. (A) DHE staining of WT and beclin 1 
heterozygous mouse heart sections after 0, 40 min and 60 min exercise training, n=3. 
(B) mRNA expression of anti-oxidant genes in sedentary or chronic trained WT and 







Table 3.1 Primer sequences for Real time-PCR. 
 
 
Gene Forward Reverse 
RPL13a CTCTGGCCTTTTCCTTTTTG CCGAAGAAGGGAGACAGTTC 
SOD1 CGGCGGATGAAGAGAGGCA TCACACGATCTTCAATGGACACA 
Catalase GCAGATACCTGTGAACTGTC GTAGAATGTCCGCACCTGAG 
Cyto C ATCTCCACGGTCTGTTCGGG TCCCCAGGTGATGCCTTTGT 
PGC-1 GTAAATCTGCGGGATGATGG AGCAGGGTCAAATCGTCTG 
NRF1 CTTCAGAACTGCCAACCACA GCTTCTGCCAGTGATGCTAC 
NRF2 AGTCTTCACCACCCCTGATC TCTGTCAGTGTGGCCTCTGG 
TFAM GCAAAGGATGATTCGGCTC TCTGCTCTTCCCAAGACTTCA 
UCP2 TTCTACAAGGGGTTCATGCC AGAAGGGTAAAGGGTGTGAG 














It is well-established that autophagy is involved in various cardiovascular 
diseases; however, the exact role of autophagy in the heart is incompletely understood. 
Moreover, the detailed molecular mechanism by which autophagy modulates cardiac 
bioenergetics and cardiac metabolism needs to be clearly elucidated.  
Before our study, there were two animal models used to study the role of 
autophagy in the heart, beclin 1 heterozygous mice and cardiac-specific ATG5 KO 
(cATG5 KO) mice. But there are some limitations for these two models. Although beclin 
1 heterozygous disruption resulted in reduced autophagy in liver and spleen, the 
constitutive autophagy in the heart of beclin 1 heterozygous mice was still preserved 
under basal conditions, which may explain the fact that the cardiac function in beclin 1 
heterozygous mice is well preserved [1]. Then cardiac-specific ATG5 KO mice were 
generated, and ATG5 deletion in the heart caused aging-dependent cardiomyopathy at 8 
months old [2]. However, ATG5 has diverse role beyond autophagy regulation. For 
example, ATG5 regulates apoptotic cell death signaling by interaction with Bcl family, 
and is also involved in necrosis signaling [3]. Thus the detrimental consequence of 
ATG5-deficiency in the heart might be the consequence of apoptosis rather than a 
secondary effect of autophagy inhibition.  
Compared to ATG5 and beclin 1, ATG3 is a more specific autophagy-related 
protein, which is required for autophagosome membrane elongation [4]. Therefore, we 
generated a novel cardiac specific autophagy deficient mouse model by deleting ATG3 






expression and blocked autophagic flux under basal and starvation conditions in a heart-
specific manner. Thus our newly generated cATG3 KO mice provide a novel animal 
model to study the role autophagy in the heart. 
Importantly, cATG3 KO mice exhibited cardiac contractile dysfunction at as early 
as 4 weeks old. More interestingly, metabolomics data showed that glycolytic and TCA 
cycle intermediates in ATG3 deficient heart were dramatically changed starting at 1 
week old, when cardiac function was still preserved. After birth, the preference of cardiac 
substrate is switched from glucose to fatty acid, which is known as metabolic switch; 
however, the mechanism of this cardiac programming is poorly understood [5]. The 
accumulation of glycolytic intermediates and decreased fatty acid oxidation gene 
expression in ATG3 deficient heart indicate autophagy may be required for this 
metabolic transmission in fetal heart. Our finding in ATG3-deficient heart reveals the 
importance of autophagy in directing cardiac metabolic programming and facilitating 
cardiac development.   
Most interestingly, we found NAD+ metabolism was dramatically altered in ATG3-
deficient hearts, characterized by increased NNMT expression and accelerated NAD+ 
breakdown. In cultured cardiomyocytes, increasing NNMT expression repressed 
mitochondrial respiration, while inhibiting NNMT activity prevented mitochondrial 
dysfunction in autophagy deficient cardiomyocytes, suggesting NNMT induction may 
contribute to the mitochondrial dysfunction in autophagy deficient heart. In previous 
studies, NNMT inhibition by anti-sense oligonucleotide or its inhibitor MeNAM prevented 
obesity and fatty liver following high-fat diet, which reflects the importance of NNMT in 
metabolic disease [6]; however, the exact role of NNMT in cardiac function was never 
studied before. Our results for the first time showed NNMT promotes NAM degradation 
to MeNAM, and exerts an adverse effect on mitochondrial respiration in the heart. So 






mediated by autophagy inhibition.   
NAD+ homeostasis has been long known to be crucial for cardiac function. For 
instance, certain agonists, such as angiotensin-II or isoproterenol, induce cardiac 
hypertrophy and heart failure by causing myocardial NAD+ depletion, and exogenous 
NAD+ blocks above cardiac hypertrophic response [7]. In our study, NMN or NR 
increased cardiac NAD+ content and rescued cardiac contractile dysfunction in cATG3 
KO mice. Our results highlight the importance of NAD+ homeostasis in maintaining 
normal heart function. 
We also demonstrate that autophagy may contribute to the beneficial effects of 
exercise training in the heart. In our study, we found that autophagy was induced in the 
heart as a response to acute and chronic exercise training. Interestingly, exercise 
training increased cardiac contractile function and enhanced cardiac mitochondrial 
respiration in WT mouse hearts, while inhibiting autophagy by heterozygous deletion of 
beclin 1 gene impaired autophagy response and blunted cardiac remodeling in response 
to exercise training. These data illustrate the important role of autophagy in maintenance 
of cardiac function in response to exercise training. 
In this study, we found that cardiac mitochondrial biogenesis, which is a very 
important adaptive response to exercise training in the heart, also requires autophagy. 
Autophagy is a general response under cellular stress conditions, and mitochondrial 
biogenesis is also upregulated in response to stress for cellular survival [8]. But it is still 
unclear how autophagy and mitochondrial biogenesis are cross-talked under stress 
conditions. Our studies identify autophagy as an important factor to induce mitochondrial 
biogenesis following exercise training in the heart.  
It is possible that autophagy induced by exercise training triggers certain 
signaling to promote mitochondrial biogenesis in the heart. Based on our finding, AMPK 






under exercise conditions. However, the detailed mechanism by which autophagy 
regulates AMPK activity following exercise training is still unclear. In future studies, it will 
be very interesting to identify potential AMPK activator or inhibitor based on our newly 
generated ATG3 KO mouse model, which may help explain how autophagy mediates 








1. Qu, X., et al., Promotion of tumorigenesis by heterozygous disruption of the 
beclin 1 autophagy gene. J Clin Invest, 2003. 112(12): p. 1809-20. 
2. Taneike, M., et al., Inhibition of autophagy in the heart induces age-related 
cardiomyopathy. Autophagy, 2010. 6(5): p. 600-6. 
3. Yousefi, S., et al., Calpain-mediated cleavage of Atg5 switches autophagy to 
apoptosis. Nat Cell Biol, 2006. 8(10): p. 1124-32. 
4. Yamaguchi, M., et al., Autophagy-related protein 8 (Atg8) family interacting motif 
in Atg3 mediates the Atg3-Atg8 interaction and is crucial for the cytoplasm-to-
vacuole targeting pathway. J Biol Chem, 2010. 285(38): p. 29599-607. 
5. Gong, G., et al., Parkin-mediated mitophagy directs perinatal cardiac metabolic 
maturation in mice. Science, 2015. 350(6265): p. aad2459. 
6. Hong, S., et al., Nicotinamide N-methyltransferase regulates hepatic nutrient 
metabolism through Sirt1 protein stabilization. Nat Med, 2015. 21(8): p. 887-94. 
7. Pillai, V.B., et al., Exogenous NAD blocks cardiac hypertrophic response via 
activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem, 2010. 
285(5): p. 3133-44. 
8. Cherry, A.D. and C.A. Piantadosi, Regulation of mitochondrial biogenesis and its 
intersection with inflammatory responses. Antioxid Redox Signal, 2015. 22(12): 
p. 965-76. 
 
 
